id	sid	tid	token	lemma	pos
cord-011793-hlktpla4	1	1	key	key	JJ
cord-011793-hlktpla4	1	2	:	:	:
cord-011793-hlktpla4	1	3	cord-011793-hlktpla4	cord-011793-hlktpla4	NN
cord-011793-hlktpla4	1	4	authors	author	NNS
cord-011793-hlktpla4	1	5	:	:	:
cord-011793-hlktpla4	1	6	Rice	Rice	NNP
cord-011793-hlktpla4	1	7	,	,	,
cord-011793-hlktpla4	1	8	Todd	Todd	NNP
cord-011793-hlktpla4	1	9	W.	W.	NNP
cord-011793-hlktpla4	1	10	;	;	:
cord-011793-hlktpla4	1	11	Janz	Janz	NNP
cord-011793-hlktpla4	1	12	,	,	,
cord-011793-hlktpla4	1	13	David	David	NNP
cord-011793-hlktpla4	1	14	R.	R.	NNP
cord-011793-hlktpla4	1	15	title	title	NN
cord-011793-hlktpla4	1	16	:	:	:
cord-011793-hlktpla4	2	1	In	in	IN
cord-011793-hlktpla4	2	2	Defense	Defense	NNP
cord-011793-hlktpla4	2	3	of	of	IN
cord-011793-hlktpla4	2	4	Evidence	evidence	NN
cord-011793-hlktpla4	2	5	-	-	HYPH
cord-011793-hlktpla4	2	6	based	base	VBN
cord-011793-hlktpla4	2	7	Medicine	Medicine	NNP
cord-011793-hlktpla4	2	8	for	for	IN
cord-011793-hlktpla4	2	9	the	the	DT
cord-011793-hlktpla4	2	10	Treatment	Treatment	NNP
cord-011793-hlktpla4	2	11	of	of	IN
cord-011793-hlktpla4	2	12	COVID-19	COVID-19	NNP
cord-011793-hlktpla4	2	13	Acute	Acute	NNP
cord-011793-hlktpla4	2	14	Respiratory	Respiratory	NNP
cord-011793-hlktpla4	2	15	Distress	Distress	NNP
cord-011793-hlktpla4	2	16	Syndrome	Syndrome	NNP
cord-011793-hlktpla4	2	17	date	date	NN
cord-011793-hlktpla4	2	18	:	:	:
cord-011793-hlktpla4	2	19	2020	2020	CD
cord-011793-hlktpla4	2	20	-	-	HYPH
cord-011793-hlktpla4	2	21	07	07	CD
cord-011793-hlktpla4	2	22	-	-	SYM
cord-011793-hlktpla4	2	23	17	17	CD
cord-011793-hlktpla4	2	24	journal	journal	NN
cord-011793-hlktpla4	2	25	:	:	:
cord-011793-hlktpla4	3	1	Ann	Ann	NNP
cord-011793-hlktpla4	3	2	Am	Am	NNP
cord-011793-hlktpla4	4	1	Thorac	Thorac	NNP
cord-011793-hlktpla4	4	2	Soc	Soc	NNP
cord-011793-hlktpla4	4	3	DOI	DOI	NNP
cord-011793-hlktpla4	4	4	:	:	:
cord-011793-hlktpla4	4	5	10.1513	10.1513	CD
cord-011793-hlktpla4	4	6	/	/	SYM
cord-011793-hlktpla4	4	7	annalsats.202004	annalsats.202004	NNP
cord-011793-hlktpla4	4	8	-	-	HYPH
cord-011793-hlktpla4	4	9	325ip	325ip	NNP
cord-011793-hlktpla4	4	10	sha	sha	NNP
cord-011793-hlktpla4	4	11	:	:	:
cord-011793-hlktpla4	5	1	7597af14544ede9a1dc53ccaa8a29dbac7dbd590	7597af14544ede9a1dc53ccaa8a29dbac7dbd590	CD
cord-011793-hlktpla4	5	2	doc_id	doc_id	CD
cord-011793-hlktpla4	5	3	:	:	:
cord-011793-hlktpla4	5	4	11793	11793	CD
cord-011793-hlktpla4	6	1	cord_uid	cord_uid	NN
cord-011793-hlktpla4	6	2	:	:	:
cord-011793-hlktpla4	7	1	hlktpla4	hlktpla4	NNP
cord-011793-hlktpla4	8	1	nan	nan	NNP
cord-011793-hlktpla4	8	2	Severe	severe	JJ
cord-011793-hlktpla4	8	3	acute	acute	JJ
cord-011793-hlktpla4	8	4	respiratory	respiratory	JJ
cord-011793-hlktpla4	8	5	failure	failure	NN
cord-011793-hlktpla4	8	6	from	from	IN
cord-011793-hlktpla4	8	7	the	the	DT
cord-011793-hlktpla4	8	8	severe	severe	JJ
cord-011793-hlktpla4	8	9	acute	acute	JJ
cord-011793-hlktpla4	8	10	respiratory	respiratory	JJ
cord-011793-hlktpla4	8	11	syndrome	syndrome	NN
cord-011793-hlktpla4	8	12	coronavirus	coronavirus	NN
cord-011793-hlktpla4	8	13	2	2	CD
cord-011793-hlktpla4	9	1	(	(	-LRB-
cord-011793-hlktpla4	9	2	SARS	SARS	NNP
cord-011793-hlktpla4	9	3	-	-	HYPH
cord-011793-hlktpla4	9	4	CoV-2	CoV-2	NNP
cord-011793-hlktpla4	9	5	)	)	-RRB-
cord-011793-hlktpla4	10	1	coronavirus	coronavirus	NN
cord-011793-hlktpla4	10	2	disease	disease	NN
cord-011793-hlktpla4	10	3	has	have	VBZ
cord-011793-hlktpla4	10	4	challenged	challenge	VBN
cord-011793-hlktpla4	10	5	intensivists	intensivist	NNS
cord-011793-hlktpla4	10	6	worldwide	worldwide	RB
cord-011793-hlktpla4	10	7	with	with	IN
cord-011793-hlktpla4	10	8	both	both	CC
cord-011793-hlktpla4	10	9	increased	increase	VBN
cord-011793-hlktpla4	10	10	severity	severity	NN
cord-011793-hlktpla4	10	11	of	of	IN
cord-011793-hlktpla4	10	12	illness	illness	NN
cord-011793-hlktpla4	10	13	and	and	CC
cord-011793-hlktpla4	10	14	quantity	quantity	NN
cord-011793-hlktpla4	10	15	of	of	IN
cord-011793-hlktpla4	10	16	patients	patient	NNS
cord-011793-hlktpla4	10	17	.	.	.
cord-011793-hlktpla4	11	1	An	an	DT
cord-011793-hlktpla4	11	2	extraordinary	extraordinary	JJ
cord-011793-hlktpla4	11	3	amount	amount	NN
cord-011793-hlktpla4	11	4	has	have	VBZ
cord-011793-hlktpla4	11	5	been	be	VBN
cord-011793-hlktpla4	11	6	published	publish	VBN
cord-011793-hlktpla4	11	7	about	about	IN
cord-011793-hlktpla4	11	8	presentation	presentation	NN
cord-011793-hlktpla4	11	9	,	,	,
cord-011793-hlktpla4	11	10	treatment	treatment	NN
cord-011793-hlktpla4	11	11	,	,	,
cord-011793-hlktpla4	11	12	and	and	CC
cord-011793-hlktpla4	11	13	outcomes	outcome	NNS
cord-011793-hlktpla4	11	14	of	of	IN
cord-011793-hlktpla4	11	15	these	these	DT
cord-011793-hlktpla4	11	16	patients	patient	NNS
cord-011793-hlktpla4	11	17	in	in	IN
cord-011793-hlktpla4	11	18	both	both	CC
cord-011793-hlktpla4	11	19	medical	medical	JJ
cord-011793-hlktpla4	11	20	journals	journal	NNS
cord-011793-hlktpla4	11	21	and	and	CC
cord-011793-hlktpla4	11	22	social	social	JJ
cord-011793-hlktpla4	11	23	media	medium	NNS
cord-011793-hlktpla4	11	24	.	.	.
cord-011793-hlktpla4	12	1	Less	Less	JJR
cord-011793-hlktpla4	12	2	than	than	IN
cord-011793-hlktpla4	12	3	6	6	CD
cord-011793-hlktpla4	12	4	months	month	NNS
cord-011793-hlktpla4	12	5	since	since	IN
cord-011793-hlktpla4	12	6	the	the	DT
cord-011793-hlktpla4	12	7	first	first	JJ
cord-011793-hlktpla4	12	8	reported	report	VBN
cord-011793-hlktpla4	12	9	case	case	NN
cord-011793-hlktpla4	12	10	,	,	,
cord-011793-hlktpla4	12	11	a	a	DT
cord-011793-hlktpla4	12	12	search	search	NN
cord-011793-hlktpla4	12	13	for	for	IN
cord-011793-hlktpla4	12	14	COVID-19	COVID-19	NNP
cord-011793-hlktpla4	12	15	in	in	IN
cord-011793-hlktpla4	12	16	PubMed	PubMed	NNP
cord-011793-hlktpla4	12	17	finds	find	VBZ
cord-011793-hlktpla4	12	18	more	more	JJR
cord-011793-hlktpla4	12	19	than	than	IN
cord-011793-hlktpla4	12	20	5,000	5,000	CD
cord-011793-hlktpla4	12	21	publications	publication	NNS
cord-011793-hlktpla4	12	22	.	.	.
cord-011793-hlktpla4	13	1	Unfortunately	unfortunately	RB
cord-011793-hlktpla4	13	2	,	,	,
cord-011793-hlktpla4	13	3	most	most	JJS
cord-011793-hlktpla4	13	4	of	of	IN
cord-011793-hlktpla4	13	5	these	these	DT
cord-011793-hlktpla4	13	6	reports	report	NNS
cord-011793-hlktpla4	13	7	are	be	VBP
cord-011793-hlktpla4	13	8	anecdotal	anecdotal	JJ
cord-011793-hlktpla4	13	9	,	,	,
cord-011793-hlktpla4	13	10	with	with	IN
cord-011793-hlktpla4	13	11	few	few	JJ
cord-011793-hlktpla4	13	12	comparative	comparative	JJ
cord-011793-hlktpla4	13	13	,	,	,
cord-011793-hlktpla4	13	14	scientific	scientific	JJ
cord-011793-hlktpla4	13	15	studies	study	NNS
cord-011793-hlktpla4	13	16	among	among	IN
cord-011793-hlktpla4	13	17	them	-PRON-	PRP
cord-011793-hlktpla4	13	18	.	.	.
cord-011793-hlktpla4	14	1	Similarly	similarly	RB
cord-011793-hlktpla4	14	2	,	,	,
cord-011793-hlktpla4	14	3	Twitter	Twitter	NNP
cord-011793-hlktpla4	14	4	and	and	CC
cord-011793-hlktpla4	14	5	other	other	JJ
cord-011793-hlktpla4	14	6	social	social	JJ
cord-011793-hlktpla4	14	7	media	medium	NNS
cord-011793-hlktpla4	14	8	platforms	platform	NNS
cord-011793-hlktpla4	14	9	have	have	VBP
cord-011793-hlktpla4	14	10	been	be	VBN
cord-011793-hlktpla4	14	11	abuzz	abuzz	JJ
cord-011793-hlktpla4	14	12	with	with	IN
cord-011793-hlktpla4	14	13	anecdotes	anecdote	NNS
cord-011793-hlktpla4	14	14	and	and	CC
cord-011793-hlktpla4	14	15	"	"	``
cord-011793-hlktpla4	14	16	expert	expert	JJ
cord-011793-hlktpla4	14	17	"	"	''
cord-011793-hlktpla4	14	18	advice	advice	NN
cord-011793-hlktpla4	14	19	as	as	IN
cord-011793-hlktpla4	14	20	to	to	IN
cord-011793-hlktpla4	14	21	how	how	WRB
cord-011793-hlktpla4	14	22	to	to	TO
cord-011793-hlktpla4	14	23	care	care	VB
cord-011793-hlktpla4	14	24	for	for	IN
cord-011793-hlktpla4	14	25	these	these	DT
cord-011793-hlktpla4	14	26	patients	patient	NNS
cord-011793-hlktpla4	14	27	.	.	.
cord-011793-hlktpla4	15	1	Many	many	JJ
cord-011793-hlktpla4	15	2	of	of	IN
cord-011793-hlktpla4	15	3	those	those	DT
cord-011793-hlktpla4	15	4	pieces	piece	NNS
cord-011793-hlktpla4	15	5	of	of	IN
cord-011793-hlktpla4	15	6	advice	advice	NN
cord-011793-hlktpla4	15	7	have	have	VBP
cord-011793-hlktpla4	15	8	represented	represent	VBN
cord-011793-hlktpla4	15	9	small	small	JJ
cord-011793-hlktpla4	15	10	-	-	HYPH
cord-011793-hlktpla4	15	11	sample	sample	NN
cord-011793-hlktpla4	15	12	clinical	clinical	JJ
cord-011793-hlktpla4	15	13	experience	experience	NN
cord-011793-hlktpla4	15	14	or	or	CC
cord-011793-hlktpla4	15	15	uncontrolled	uncontrolled	JJ
cord-011793-hlktpla4	15	16	experiments	experiment	NNS
cord-011793-hlktpla4	15	17	,	,	,
cord-011793-hlktpla4	15	18	often	often	RB
cord-011793-hlktpla4	15	19	without	without	IN
cord-011793-hlktpla4	15	20	consent	consent	NN
cord-011793-hlktpla4	15	21	or	or	CC
cord-011793-hlktpla4	15	22	regulatory	regulatory	JJ
cord-011793-hlktpla4	15	23	oversight	oversight	NN
cord-011793-hlktpla4	15	24	,	,	,
cord-011793-hlktpla4	15	25	with	with	IN
cord-011793-hlktpla4	15	26	offlabel	offlabel	NNP
cord-011793-hlktpla4	15	27	uses	use	VBZ
cord-011793-hlktpla4	15	28	of	of	IN
cord-011793-hlktpla4	15	29	already	already	RB
cord-011793-hlktpla4	15	30	-	-	HYPH
cord-011793-hlktpla4	15	31	approved	approve	VBN
cord-011793-hlktpla4	15	32	medications	medication	NNS
cord-011793-hlktpla4	15	33	aimed	aim	VBN
cord-011793-hlktpla4	15	34	at	at	IN
cord-011793-hlktpla4	15	35	treating	treat	VBG
cord-011793-hlktpla4	15	36	some	some	DT
cord-011793-hlktpla4	15	37	mechanistic	mechanistic	JJ
cord-011793-hlktpla4	15	38	pathway	pathway	NN
cord-011793-hlktpla4	15	39	or	or	CC
cord-011793-hlktpla4	15	40	presumed	presume	VBN
cord-011793-hlktpla4	15	41	pathophysiology	pathophysiology	NN
cord-011793-hlktpla4	15	42	extrapolated	extrapolate	VBN
cord-011793-hlktpla4	15	43	from	from	IN
cord-011793-hlktpla4	15	44	a	a	DT
cord-011793-hlktpla4	15	45	limited	limited	JJ
cord-011793-hlktpla4	15	46	number	number	NN
cord-011793-hlktpla4	15	47	of	of	IN
cord-011793-hlktpla4	15	48	these	these	DT
cord-011793-hlktpla4	15	49	patients	patient	NNS
cord-011793-hlktpla4	15	50	.	.	.
cord-011793-hlktpla4	16	1	For	for	IN
cord-011793-hlktpla4	16	2	example	example	NN
cord-011793-hlktpla4	16	3	,	,	,
cord-011793-hlktpla4	16	4	on	on	IN
cord-011793-hlktpla4	16	5	the	the	DT
cord-011793-hlktpla4	16	6	basis	basis	NN
cord-011793-hlktpla4	16	7	of	of	IN
cord-011793-hlktpla4	16	8	a	a	DT
cord-011793-hlktpla4	16	9	case	case	NN
cord-011793-hlktpla4	16	10	series	series	NN
cord-011793-hlktpla4	16	11	of	of	IN
cord-011793-hlktpla4	16	12	21	21	CD
cord-011793-hlktpla4	16	13	patients	patient	NNS
cord-011793-hlktpla4	16	14	published	publish	VBN
cord-011793-hlktpla4	16	15	in	in	IN
cord-011793-hlktpla4	16	16	a	a	DT
cord-011793-hlktpla4	16	17	Chinese	chinese	JJ
cord-011793-hlktpla4	16	18	preprint	preprint	NN
cord-011793-hlktpla4	16	19	(	(	-LRB-
cord-011793-hlktpla4	16	20	1	1	CD
cord-011793-hlktpla4	16	21	)	)	-RRB-
cord-011793-hlktpla4	16	22	,	,	,
cord-011793-hlktpla4	16	23	off	off	IN
cord-011793-hlktpla4	16	24	-	-	HYPH
cord-011793-hlktpla4	16	25	label	label	NN
cord-011793-hlktpla4	16	26	use	use	NN
cord-011793-hlktpla4	16	27	of	of	IN
cord-011793-hlktpla4	16	28	the	the	DT
cord-011793-hlktpla4	16	29	interleukin-6	interleukin-6	NNP
cord-011793-hlktpla4	16	30	receptor	receptor	NN
cord-011793-hlktpla4	16	31	antagonist	antagonist	NN
cord-011793-hlktpla4	16	32	tocilizumab	tocilizumab	NNP
cord-011793-hlktpla4	16	33	has	have	VBZ
cord-011793-hlktpla4	16	34	been	be	VBN
cord-011793-hlktpla4	16	35	proposed	propose	VBN
cord-011793-hlktpla4	16	36	to	to	TO
cord-011793-hlktpla4	16	37	treat	treat	VB
cord-011793-hlktpla4	16	38	the	the	DT
cord-011793-hlktpla4	16	39	"	"	``
cord-011793-hlktpla4	16	40	cytokine	cytokine	NN
cord-011793-hlktpla4	16	41	storm	storm	NN
cord-011793-hlktpla4	16	42	"	"	''
cord-011793-hlktpla4	16	43	that	that	WDT
cord-011793-hlktpla4	16	44	many	many	JJ
cord-011793-hlktpla4	16	45	have	have	VBP
cord-011793-hlktpla4	16	46	postulated	postulate	VBN
cord-011793-hlktpla4	16	47	causes	cause	VBZ
cord-011793-hlktpla4	16	48	the	the	DT
cord-011793-hlktpla4	16	49	multisystem	multisystem	JJ
cord-011793-hlktpla4	16	50	organ	organ	NN
cord-011793-hlktpla4	16	51	dysfunction	dysfunction	NN
cord-011793-hlktpla4	16	52	seen	see	VBN
cord-011793-hlktpla4	16	53	with	with	IN
cord-011793-hlktpla4	16	54	critically	critically	RB
cord-011793-hlktpla4	16	55	ill	ill	JJ
cord-011793-hlktpla4	16	56	patients	patient	NNS
cord-011793-hlktpla4	16	57	with	with	IN
cord-011793-hlktpla4	16	58	COVID-19	COVID-19	NNP
cord-011793-hlktpla4	16	59	.	.	.
cord-011793-hlktpla4	17	1	Recently	recently	RB
cord-011793-hlktpla4	17	2	,	,	,
cord-011793-hlktpla4	17	3	off	off	IN
cord-011793-hlktpla4	17	4	-	-	HYPH
cord-011793-hlktpla4	17	5	label	label	NN
cord-011793-hlktpla4	17	6	use	use	NN
cord-011793-hlktpla4	17	7	of	of	IN
cord-011793-hlktpla4	17	8	inhaled	inhale	VBN
cord-011793-hlktpla4	17	9	nitric	nitric	NN
cord-011793-hlktpla4	17	10	oxide	oxide	NN
cord-011793-hlktpla4	17	11	to	to	TO
cord-011793-hlktpla4	17	12	prevent	prevent	VB
cord-011793-hlktpla4	17	13	intubation	intubation	NN
cord-011793-hlktpla4	17	14	and	and	CC
cord-011793-hlktpla4	17	15	empiric	empiric	JJ
cord-011793-hlktpla4	17	16	anticoagulation	anticoagulation	NN
cord-011793-hlktpla4	17	17	or	or	CC
cord-011793-hlktpla4	17	18	thrombolysis	thrombolysis	NN
cord-011793-hlktpla4	17	19	to	to	TO
cord-011793-hlktpla4	17	20	treat	treat	VB
cord-011793-hlktpla4	17	21	the	the	DT
cord-011793-hlktpla4	17	22	microthromboses	microthrombose	NNS
cord-011793-hlktpla4	17	23	seen	see	VBN
cord-011793-hlktpla4	17	24	in	in	IN
cord-011793-hlktpla4	17	25	the	the	DT
cord-011793-hlktpla4	17	26	lungs	lung	NNS
cord-011793-hlktpla4	17	27	on	on	IN
cord-011793-hlktpla4	17	28	autopsy	autopsy	JJ
cord-011793-hlktpla4	17	29	(	(	-LRB-
cord-011793-hlktpla4	17	30	2	2	LS
cord-011793-hlktpla4	17	31	)	)	-RRB-
cord-011793-hlktpla4	17	32	has	have	VBZ
cord-011793-hlktpla4	17	33	also	also	RB
cord-011793-hlktpla4	17	34	been	be	VBN
cord-011793-hlktpla4	17	35	proposed	propose	VBN
cord-011793-hlktpla4	17	36	.	.	.
cord-011793-hlktpla4	18	1	Although	although	IN
cord-011793-hlktpla4	18	2	many	many	JJ
cord-011793-hlktpla4	18	3	effective	effective	JJ
cord-011793-hlktpla4	18	4	treatments	treatment	NNS
cord-011793-hlktpla4	18	5	start	start	VBP
cord-011793-hlktpla4	18	6	with	with	IN
cord-011793-hlktpla4	18	7	similar	similar	JJ
cord-011793-hlktpla4	18	8	postulates	postulate	NNS
cord-011793-hlktpla4	18	9	,	,	,
cord-011793-hlktpla4	18	10	these	these	DT
cord-011793-hlktpla4	18	11	modalities	modality	NNS
cord-011793-hlktpla4	18	12	can	can	MD
cord-011793-hlktpla4	18	13	only	only	RB
cord-011793-hlktpla4	18	14	demonstrate	demonstrate	VB
cord-011793-hlktpla4	18	15	effectiveness	effectiveness	NN
cord-011793-hlktpla4	18	16	,	,	,
cord-011793-hlktpla4	18	17	and	and	CC
cord-011793-hlktpla4	18	18	thus	thus	RB
cord-011793-hlktpla4	18	19	become	become	VB
cord-011793-hlktpla4	18	20	evidencebased	evidencebased	JJ
cord-011793-hlktpla4	18	21	treatments	treatment	NNS
cord-011793-hlktpla4	18	22	,	,	,
cord-011793-hlktpla4	18	23	in	in	IN
cord-011793-hlktpla4	18	24	well	well	RB
cord-011793-hlktpla4	18	25	-	-	HYPH
cord-011793-hlktpla4	18	26	designed	design	VBN
cord-011793-hlktpla4	18	27	,	,	,
cord-011793-hlktpla4	18	28	placebocontrolled	placebocontrolled	JJ
cord-011793-hlktpla4	18	29	randomized	randomized	JJ
cord-011793-hlktpla4	18	30	trials	trial	NNS
cord-011793-hlktpla4	18	31	.	.	.
cord-011793-hlktpla4	19	1	All	all	RB
cord-011793-hlktpla4	19	2	too	too	RB
cord-011793-hlktpla4	19	3	often	often	RB
cord-011793-hlktpla4	19	4	in	in	IN
cord-011793-hlktpla4	19	5	critical	critical	JJ
cord-011793-hlktpla4	19	6	care	care	NN
cord-011793-hlktpla4	19	7	,	,	,
cord-011793-hlktpla4	19	8	hypotheses	hypothesis	NNS
cord-011793-hlktpla4	19	9	based	base	VBN
cord-011793-hlktpla4	19	10	on	on	IN
cord-011793-hlktpla4	19	11	mechanism	mechanism	NN
cord-011793-hlktpla4	19	12	and	and	CC
cord-011793-hlktpla4	19	13	observation	observation	NN
cord-011793-hlktpla4	19	14	failed	fail	VBD
cord-011793-hlktpla4	19	15	the	the	DT
cord-011793-hlktpla4	19	16	test	test	NN
cord-011793-hlktpla4	19	17	of	of	IN
cord-011793-hlktpla4	19	18	the	the	DT
cord-011793-hlktpla4	19	19	randomized	randomized	JJ
cord-011793-hlktpla4	19	20	trial	trial	NN
cord-011793-hlktpla4	19	21	.	.	.
cord-011793-hlktpla4	20	1	The	the	DT
cord-011793-hlktpla4	20	2	arguments	argument	NNS
cord-011793-hlktpla4	20	3	on	on	IN
cord-011793-hlktpla4	20	4	social	social	JJ
cord-011793-hlktpla4	20	5	media	medium	NNS
cord-011793-hlktpla4	20	6	are	be	VBP
cord-011793-hlktpla4	20	7	based	base	VBN
cord-011793-hlktpla4	20	8	more	more	RBR
cord-011793-hlktpla4	20	9	in	in	IN
cord-011793-hlktpla4	20	10	emotion	emotion	NN
cord-011793-hlktpla4	20	11	than	than	IN
cord-011793-hlktpla4	20	12	science	science	NN
cord-011793-hlktpla4	20	13	.	.	.
cord-011793-hlktpla4	21	1	"	"	``
cord-011793-hlktpla4	21	2	We	-PRON-	PRP
cord-011793-hlktpla4	21	3	can	can	MD
cord-011793-hlktpla4	21	4	not	not	RB
cord-011793-hlktpla4	21	5	just	just	RB
cord-011793-hlktpla4	21	6	do	do	VB
cord-011793-hlktpla4	21	7	nothing	nothing	NN
cord-011793-hlktpla4	21	8	for	for	IN
cord-011793-hlktpla4	21	9	these	these	DT
cord-011793-hlktpla4	21	10	patients	patient	NNS
cord-011793-hlktpla4	21	11	.	.	.
cord-011793-hlktpla4	21	12	"	"	``
cord-011793-hlktpla4	21	13	As	as	RB
cord-011793-hlktpla4	21	14	much	much	RB
cord-011793-hlktpla4	21	15	as	as	IN
cord-011793-hlktpla4	21	16	the	the	DT
cord-011793-hlktpla4	21	17	"	"	``
cord-011793-hlktpla4	21	18	do	do	VBP
cord-011793-hlktpla4	21	19	n't	not	RB
cord-011793-hlktpla4	21	20	just	just	RB
cord-011793-hlktpla4	21	21	stand	stand	VB
cord-011793-hlktpla4	21	22	there	there	RB
cord-011793-hlktpla4	21	23	,	,	,
cord-011793-hlktpla4	21	24	do	do	VB
cord-011793-hlktpla4	21	25	something	something	NN
cord-011793-hlktpla4	21	26	"	"	``
cord-011793-hlktpla4	21	27	feeling	feeling	NN
cord-011793-hlktpla4	21	28	is	be	VBZ
cord-011793-hlktpla4	21	29	real	real	JJ
cord-011793-hlktpla4	21	30	,	,	,
cord-011793-hlktpla4	21	31	it	-PRON-	PRP
cord-011793-hlktpla4	21	32	is	be	VBZ
cord-011793-hlktpla4	21	33	also	also	RB
cord-011793-hlktpla4	21	34	likely	likely	RB
cord-011793-hlktpla4	21	35	dangerous	dangerous	JJ
cord-011793-hlktpla4	21	36	to	to	IN
cord-011793-hlktpla4	21	37	our	-PRON-	PRP$
cord-011793-hlktpla4	21	38	patients	patient	NNS
cord-011793-hlktpla4	21	39	.	.	.
cord-011793-hlktpla4	22	1	The	the	DT
cord-011793-hlktpla4	22	2	prevailing	prevail	VBG
cord-011793-hlktpla4	22	3	evidence	evidence	NN
cord-011793-hlktpla4	22	4	in	in	IN
cord-011793-hlktpla4	22	5	critical	critical	JJ
cord-011793-hlktpla4	22	6	care	care	NN
cord-011793-hlktpla4	22	7	suggests	suggest	VBZ
cord-011793-hlktpla4	22	8	that	that	IN
cord-011793-hlktpla4	22	9	"	"	``
cord-011793-hlktpla4	22	10	doing	do	VBG
cord-011793-hlktpla4	22	11	less	less	RBR
cord-011793-hlktpla4	22	12	is	be	VBZ
cord-011793-hlktpla4	22	13	more	more	JJR
cord-011793-hlktpla4	22	14	,	,	,
cord-011793-hlktpla4	22	15	"	"	''
cord-011793-hlktpla4	22	16	as	as	IN
cord-011793-hlktpla4	22	17	the	the	DT
cord-011793-hlktpla4	22	18	more	more	RBR
cord-011793-hlktpla4	22	19	we	-PRON-	PRP
cord-011793-hlktpla4	22	20	try	try	VBP
cord-011793-hlktpla4	22	21	to	to	TO
cord-011793-hlktpla4	22	22	interfere	interfere	VB
cord-011793-hlktpla4	22	23	or	or	CC
cord-011793-hlktpla4	22	24	disrupt	disrupt	VB
cord-011793-hlktpla4	22	25	the	the	DT
cord-011793-hlktpla4	22	26	pathways	pathway	NNS
cord-011793-hlktpla4	22	27	of	of	IN
cord-011793-hlktpla4	22	28	critical	critical	JJ
cord-011793-hlktpla4	22	29	illness	illness	NN
cord-011793-hlktpla4	22	30	,	,	,
cord-011793-hlktpla4	22	31	the	the	DT
cord-011793-hlktpla4	22	32	worse	bad	JJR
cord-011793-hlktpla4	22	33	the	the	DT
cord-011793-hlktpla4	22	34	patient	patient	NN
cord-011793-hlktpla4	22	35	outcomes	outcome	NNS
cord-011793-hlktpla4	22	36	.	.	.
cord-011793-hlktpla4	23	1	The	the	DT
cord-011793-hlktpla4	23	2	inflammatory	inflammatory	JJ
cord-011793-hlktpla4	23	3	and	and	CC
cord-011793-hlktpla4	23	4	coagulation	coagulation	NN
cord-011793-hlktpla4	23	5	cascades	cascade	NNS
cord-011793-hlktpla4	23	6	of	of	IN
cord-011793-hlktpla4	23	7	critical	critical	JJ
cord-011793-hlktpla4	23	8	illness	illness	NN
cord-011793-hlktpla4	23	9	are	be	VBP
cord-011793-hlktpla4	23	10	intertwined	intertwine	VBN
cord-011793-hlktpla4	23	11	,	,	,
cord-011793-hlktpla4	23	12	complicated	complicated	JJ
cord-011793-hlktpla4	23	13	,	,	,
cord-011793-hlktpla4	23	14	and	and	CC
cord-011793-hlktpla4	23	15	still	still	RB
cord-011793-hlktpla4	23	16	poorly	poorly	RB
cord-011793-hlktpla4	23	17	understood	understand	VBN
cord-011793-hlktpla4	23	18	.	.	.
cord-011793-hlktpla4	24	1	To	to	TO
cord-011793-hlktpla4	24	2	assume	assume	VB
cord-011793-hlktpla4	24	3	that	that	IN
cord-011793-hlktpla4	24	4	we	-PRON-	PRP
cord-011793-hlktpla4	24	5	can	can	MD
cord-011793-hlktpla4	24	6	target	target	VB
cord-011793-hlktpla4	24	7	pathways	pathway	NNS
cord-011793-hlktpla4	24	8	in	in	IN
cord-011793-hlktpla4	24	9	either	either	DT
cord-011793-hlktpla4	24	10	or	or	CC
cord-011793-hlktpla4	24	11	both	both	DT
cord-011793-hlktpla4	24	12	cascades	cascade	NNS
cord-011793-hlktpla4	24	13	and	and	CC
cord-011793-hlktpla4	24	14	improve	improve	VB
cord-011793-hlktpla4	24	15	the	the	DT
cord-011793-hlktpla4	24	16	outcomes	outcome	NNS
cord-011793-hlktpla4	24	17	of	of	IN
cord-011793-hlktpla4	24	18	our	-PRON-	PRP$
cord-011793-hlktpla4	24	19	patients	patient	NNS
cord-011793-hlktpla4	24	20	is	be	VBZ
cord-011793-hlktpla4	24	21	naive	naive	JJ
cord-011793-hlktpla4	24	22	and	and	CC
cord-011793-hlktpla4	24	23	hubristic	hubristic	JJ
cord-011793-hlktpla4	24	24	,	,	,
cord-011793-hlktpla4	24	25	as	as	IN
cord-011793-hlktpla4	24	26	we	-PRON-	PRP
cord-011793-hlktpla4	24	27	have	have	VBP
cord-011793-hlktpla4	24	28	seen	see	VBN
cord-011793-hlktpla4	24	29	numerous	numerous	JJ
cord-011793-hlktpla4	24	30	times	time	NNS
cord-011793-hlktpla4	24	31	in	in	IN
cord-011793-hlktpla4	24	32	the	the	DT
cord-011793-hlktpla4	24	33	past	past	NN
cord-011793-hlktpla4	24	34	with	with	IN
cord-011793-hlktpla4	24	35	failed	fail	VBN
cord-011793-hlktpla4	24	36	randomized	randomized	JJ
cord-011793-hlktpla4	24	37	trials	trial	NNS
cord-011793-hlktpla4	24	38	of	of	IN
cord-011793-hlktpla4	24	39	antiinflammatory	antiinflammatory	JJ
cord-011793-hlktpla4	24	40	and	and	CC
cord-011793-hlktpla4	24	41	anticoagulant	anticoagulant	JJ
cord-011793-hlktpla4	24	42	agents	agent	NNS
cord-011793-hlktpla4	24	43	,	,	,
cord-011793-hlktpla4	24	44	such	such	JJ
cord-011793-hlktpla4	24	45	as	as	IN
cord-011793-hlktpla4	24	46	anti	anti	JJ
cord-011793-hlktpla4	24	47	-	-	JJ
cord-011793-hlktpla4	24	48	TNF	TNF	NNP
cord-011793-hlktpla4	24	49	(	(	-LRB-
cord-011793-hlktpla4	24	50	3	3	CD
cord-011793-hlktpla4	24	51	)	)	-RRB-
cord-011793-hlktpla4	24	52	,	,	,
cord-011793-hlktpla4	24	53	b	b	NN
cord-011793-hlktpla4	24	54	-	-	:
cord-011793-hlktpla4	24	55	interferon	interferon	NNP
cord-011793-hlktpla4	24	56	(	(	-LRB-
cord-011793-hlktpla4	24	57	4	4	CD
cord-011793-hlktpla4	24	58	)	)	-RRB-
cord-011793-hlktpla4	24	59	,	,	,
cord-011793-hlktpla4	24	60	recombinant	recombinant	JJ
cord-011793-hlktpla4	24	61	human	human	NN
cord-011793-hlktpla4	24	62	activated	activate	VBN
cord-011793-hlktpla4	24	63	protein	protein	NN
cord-011793-hlktpla4	24	64	C	C	NNP
cord-011793-hlktpla4	24	65	(	(	-LRB-
cord-011793-hlktpla4	24	66	5	5	CD
cord-011793-hlktpla4	24	67	)	)	-RRB-
cord-011793-hlktpla4	24	68	,	,	,
cord-011793-hlktpla4	24	69	and	and	CC
cord-011793-hlktpla4	24	70	statins	statin	NNS
cord-011793-hlktpla4	24	71	(	(	-LRB-
cord-011793-hlktpla4	24	72	6	6	CD
cord-011793-hlktpla4	24	73	)	)	-RRB-
cord-011793-hlktpla4	24	74	.	.	.
cord-011793-hlktpla4	25	1	Novel	novel	JJ
cord-011793-hlktpla4	25	2	treatments	treatment	NNS
cord-011793-hlktpla4	25	3	must	must	MD
cord-011793-hlktpla4	25	4	be	be	VB
cord-011793-hlktpla4	25	5	studied	study	VBN
cord-011793-hlktpla4	25	6	in	in	IN
cord-011793-hlktpla4	25	7	randomized	randomized	JJ
cord-011793-hlktpla4	25	8	controlled	control	VBN
cord-011793-hlktpla4	25	9	trials	trial	NNS
cord-011793-hlktpla4	25	10	to	to	TO
cord-011793-hlktpla4	25	11	truly	truly	RB
cord-011793-hlktpla4	25	12	understand	understand	VB
cord-011793-hlktpla4	25	13	both	both	CC
cord-011793-hlktpla4	25	14	their	-PRON-	PRP$
cord-011793-hlktpla4	25	15	benefits	benefit	NNS
cord-011793-hlktpla4	25	16	and	and	CC
cord-011793-hlktpla4	25	17	their	-PRON-	PRP$
cord-011793-hlktpla4	25	18	risks	risk	NNS
cord-011793-hlktpla4	25	19	(	(	-LRB-
cord-011793-hlktpla4	25	20	7	7	CD
cord-011793-hlktpla4	25	21	)	)	-RRB-
cord-011793-hlktpla4	25	22	,	,	,
cord-011793-hlktpla4	25	23	especially	especially	RB
cord-011793-hlktpla4	25	24	because	because	IN
cord-011793-hlktpla4	25	25	recent	recent	JJ
cord-011793-hlktpla4	25	26	data	datum	NNS
cord-011793-hlktpla4	25	27	suggest	suggest	VBP
cord-011793-hlktpla4	25	28	about	about	IN
cord-011793-hlktpla4	25	29	95	95	CD
cord-011793-hlktpla4	25	30	%	%	NN
cord-011793-hlktpla4	25	31	of	of	IN
cord-011793-hlktpla4	25	32	critical	critical	JJ
cord-011793-hlktpla4	25	33	care	care	NN
cord-011793-hlktpla4	25	34	trials	trial	NNS
cord-011793-hlktpla4	25	35	fail	fail	VBP
cord-011793-hlktpla4	25	36	to	to	TO
cord-011793-hlktpla4	25	37	demonstrate	demonstrate	VB
cord-011793-hlktpla4	25	38	benefit	benefit	NN
cord-011793-hlktpla4	25	39	(	(	-LRB-
cord-011793-hlktpla4	25	40	8)	8)	NN
cord-011793-hlktpla4	25	41	,	,	,
cord-011793-hlktpla4	25	42	rendering	render	VBG
cord-011793-hlktpla4	25	43	the	the	DT
cord-011793-hlktpla4	25	44	pretest	pretest	NN
cord-011793-hlktpla4	25	45	probability	probability	NN
cord-011793-hlktpla4	25	46	very	very	RB
cord-011793-hlktpla4	25	47	low	low	JJ
cord-011793-hlktpla4	25	48	.	.	.
cord-011793-hlktpla4	26	1	Yet	yet	RB
cord-011793-hlktpla4	26	2	many	many	JJ
cord-011793-hlktpla4	26	3	of	of	IN
cord-011793-hlktpla4	26	4	the	the	DT
cord-011793-hlktpla4	26	5	past	past	JJ
cord-011793-hlktpla4	26	6	30	30	CD
cord-011793-hlktpla4	26	7	years	year	NNS
cord-011793-hlktpla4	26	8	of	of	IN
cord-011793-hlktpla4	26	9	failed	fail	VBN
cord-011793-hlktpla4	26	10	critical	critical	JJ
cord-011793-hlktpla4	26	11	care	care	NN
cord-011793-hlktpla4	26	12	research	research	NN
cord-011793-hlktpla4	26	13	hypotheses	hypothesis	NNS
cord-011793-hlktpla4	26	14	have	have	VBP
cord-011793-hlktpla4	26	15	been	be	VBN
cord-011793-hlktpla4	26	16	resurrected	resurrect	VBN
cord-011793-hlktpla4	26	17	in	in	IN
cord-011793-hlktpla4	26	18	hopes	hope	NNS
cord-011793-hlktpla4	26	19	of	of	IN
cord-011793-hlktpla4	26	20	providing	provide	VBG
cord-011793-hlktpla4	26	21	novel	novel	JJ
cord-011793-hlktpla4	26	22	COVID-19	covid-19	CD
cord-011793-hlktpla4	26	23	treatments	treatment	NNS
cord-011793-hlktpla4	26	24	.	.	.
cord-011793-hlktpla4	27	1	Although	although	IN
cord-011793-hlktpla4	27	2	the	the	DT
cord-011793-hlktpla4	27	3	desire	desire	NN
cord-011793-hlktpla4	27	4	to	to	TO
cord-011793-hlktpla4	27	5	try	try	VB
cord-011793-hlktpla4	27	6	to	to	TO
cord-011793-hlktpla4	27	7	treat	treat	VB
cord-011793-hlktpla4	27	8	these	these	DT
cord-011793-hlktpla4	27	9	patients	patient	NNS
cord-011793-hlktpla4	27	10	with	with	IN
cord-011793-hlktpla4	27	11	already	already	RB
cord-011793-hlktpla4	27	12	approved	approve	VBN
cord-011793-hlktpla4	27	13	drugs	drug	NNS
cord-011793-hlktpla4	27	14	is	be	VBZ
cord-011793-hlktpla4	27	15	understandable	understandable	JJ
cord-011793-hlktpla4	27	16	,	,	,
cord-011793-hlktpla4	27	17	what	what	WP
cord-011793-hlktpla4	27	18	is	be	VBZ
cord-011793-hlktpla4	27	19	less	less	RBR
cord-011793-hlktpla4	27	20	understandable	understandable	JJ
cord-011793-hlktpla4	27	21	is	be	VBZ
cord-011793-hlktpla4	27	22	the	the	DT
cord-011793-hlktpla4	27	23	desire	desire	NN
cord-011793-hlktpla4	27	24	in	in	IN
cord-011793-hlktpla4	27	25	medical	medical	JJ
cord-011793-hlktpla4	27	26	publications	publication	NNS
cord-011793-hlktpla4	27	27	and	and	CC
cord-011793-hlktpla4	27	28	on	on	IN
cord-011793-hlktpla4	27	29	social	social	JJ
cord-011793-hlktpla4	27	30	media	medium	NNS
cord-011793-hlktpla4	27	31	to	to	TO
cord-011793-hlktpla4	27	32	abandon	abandon	VB
cord-011793-hlktpla4	27	33	the	the	DT
cord-011793-hlktpla4	27	34	principles	principle	NNS
cord-011793-hlktpla4	27	35	of	of	IN
cord-011793-hlktpla4	27	36	evidence	evidence	NN
cord-011793-hlktpla4	27	37	-	-	HYPH
cord-011793-hlktpla4	27	38	based	base	VBN
cord-011793-hlktpla4	27	39	critical	critical	JJ
cord-011793-hlktpla4	27	40	care	care	NN
cord-011793-hlktpla4	27	41	that	that	WDT
cord-011793-hlktpla4	27	42	we	-PRON-	PRP
cord-011793-hlktpla4	27	43	have	have	VBP
cord-011793-hlktpla4	27	44	established	establish	VBN
cord-011793-hlktpla4	27	45	over	over	IN
cord-011793-hlktpla4	27	46	the	the	DT
cord-011793-hlktpla4	27	47	last	last	JJ
cord-011793-hlktpla4	27	48	3	3	CD
cord-011793-hlktpla4	27	49	decades	decade	NNS
cord-011793-hlktpla4	27	50	(	(	-LRB-
cord-011793-hlktpla4	27	51	9	9	CD
cord-011793-hlktpla4	27	52	)	)	-RRB-
cord-011793-hlktpla4	27	53	,	,	,
cord-011793-hlktpla4	27	54	because	because	IN
cord-011793-hlktpla4	27	55	"	"	``
cord-011793-hlktpla4	27	56	I	-PRON-	PRP
cord-011793-hlktpla4	27	57	have	have	VBP
cord-011793-hlktpla4	27	58	never	never	RB
cord-011793-hlktpla4	27	59	seen	see	VBN
cord-011793-hlktpla4	27	60	patients	patient	NNS
cord-011793-hlktpla4	27	61	with	with	IN
cord-011793-hlktpla4	27	62	ARDS	ARDS	NNP
cord-011793-hlktpla4	27	63	act	act	VBP
cord-011793-hlktpla4	27	64	like	like	IN
cord-011793-hlktpla4	27	65	this	this	DT
cord-011793-hlktpla4	27	66	.	.	.
cord-011793-hlktpla4	28	1	"	"	''
cord-011793-hlktpla4	29	1	Large	large	JJ
cord-011793-hlktpla4	29	2	,	,	,
cord-011793-hlktpla4	29	3	well	well	RB
cord-011793-hlktpla4	29	4	-	-	HYPH
cord-011793-hlktpla4	29	5	designed	design	VBN
cord-011793-hlktpla4	29	6	,	,	,
cord-011793-hlktpla4	29	7	multicenter	multicenter	JJ
cord-011793-hlktpla4	29	8	randomized	randomized	JJ
cord-011793-hlktpla4	29	9	trials	trial	NNS
cord-011793-hlktpla4	29	10	have	have	VBP
cord-011793-hlktpla4	29	11	set	set	VBN
cord-011793-hlktpla4	29	12	the	the	DT
cord-011793-hlktpla4	29	13	foundation	foundation	NN
cord-011793-hlktpla4	29	14	of	of	IN
cord-011793-hlktpla4	29	15	an	an	DT
cord-011793-hlktpla4	29	16	evidence	evidence	NN
cord-011793-hlktpla4	29	17	-	-	HYPH
cord-011793-hlktpla4	29	18	based	base	VBN
cord-011793-hlktpla4	29	19	practice	practice	NN
cord-011793-hlktpla4	29	20	of	of	IN
cord-011793-hlktpla4	29	21	how	how	WRB
cord-011793-hlktpla4	29	22	to	to	TO
cord-011793-hlktpla4	29	23	produce	produce	VB
cord-011793-hlktpla4	29	24	the	the	DT
cord-011793-hlktpla4	29	25	best	good	JJS
cord-011793-hlktpla4	29	26	outcomes	outcome	NNS
cord-011793-hlktpla4	29	27	for	for	IN
cord-011793-hlktpla4	29	28	critically	critically	RB
cord-011793-hlktpla4	29	29	ill	ill	JJ
cord-011793-hlktpla4	29	30	patients	patient	NNS
cord-011793-hlktpla4	29	31	.	.	.
cord-011793-hlktpla4	30	1	Abandonment	abandonment	NN
cord-011793-hlktpla4	30	2	of	of	IN
cord-011793-hlktpla4	30	3	these	these	DT
cord-011793-hlktpla4	30	4	principles	principle	NNS
cord-011793-hlktpla4	30	5	in	in	IN
cord-011793-hlktpla4	30	6	the	the	DT
cord-011793-hlktpla4	30	7	face	face	NN
cord-011793-hlktpla4	30	8	of	of	IN
cord-011793-hlktpla4	30	9	this	this	DT
cord-011793-hlktpla4	30	10	pandemic	pandemic	NN
cord-011793-hlktpla4	30	11	,	,	,
cord-011793-hlktpla4	30	12	without	without	IN
cord-011793-hlktpla4	30	13	any	any	DT
cord-011793-hlktpla4	30	14	supporting	support	VBG
cord-011793-hlktpla4	30	15	scientific	scientific	JJ
cord-011793-hlktpla4	30	16	data	datum	NNS
cord-011793-hlktpla4	30	17	,	,	,
cord-011793-hlktpla4	30	18	simply	simply	RB
cord-011793-hlktpla4	30	19	because	because	IN
cord-011793-hlktpla4	30	20	we	-PRON-	PRP
cord-011793-hlktpla4	30	21	are	be	VBP
cord-011793-hlktpla4	30	22	scared	scared	JJ
cord-011793-hlktpla4	30	23	or	or	CC
cord-011793-hlktpla4	30	24	overwhelmed	overwhelmed	JJ
cord-011793-hlktpla4	30	25	,	,	,
cord-011793-hlktpla4	30	26	because	because	IN
cord-011793-hlktpla4	30	27	we	-PRON-	PRP
cord-011793-hlktpla4	30	28	believe	believe	VBP
cord-011793-hlktpla4	30	29	after	after	IN
cord-011793-hlktpla4	30	30	a	a	DT
cord-011793-hlktpla4	30	31	few	few	JJ
cord-011793-hlktpla4	30	32	months	month	NNS
cord-011793-hlktpla4	30	33	of	of	IN
cord-011793-hlktpla4	30	34	anecdotal	anecdotal	JJ
cord-011793-hlktpla4	30	35	experience	experience	NN
cord-011793-hlktpla4	30	36	that	that	WDT
cord-011793-hlktpla4	30	37	we	-PRON-	PRP
cord-011793-hlktpla4	30	38	have	have	VBP
cord-011793-hlktpla4	30	39	recognized	recognize	VBN
cord-011793-hlktpla4	30	40	an	an	DT
cord-011793-hlktpla4	30	41	entirely	entirely	RB
cord-011793-hlktpla4	30	42	unique	unique	JJ
cord-011793-hlktpla4	30	43	syndrome	syndrome	NN
cord-011793-hlktpla4	30	44	,	,	,
cord-011793-hlktpla4	30	45	or	or	CC
cord-011793-hlktpla4	30	46	because	because	IN
cord-011793-hlktpla4	30	47	we	-PRON-	PRP
cord-011793-hlktpla4	30	48	have	have	VBP
cord-011793-hlktpla4	30	49	not	not	RB
cord-011793-hlktpla4	30	50	had	have	VBN
cord-011793-hlktpla4	30	51	time	time	NN
cord-011793-hlktpla4	30	52	to	to	TO
cord-011793-hlktpla4	30	53	conduct	conduct	VB
cord-011793-hlktpla4	30	54	randomized	randomize	VBN
cord-011793-hlktpla4	30	55	controlled	control	VBN
cord-011793-hlktpla4	30	56	trials	trial	NNS
cord-011793-hlktpla4	30	57	specifically	specifically	RB
cord-011793-hlktpla4	30	58	in	in	IN
cord-011793-hlktpla4	30	59	these	these	DT
cord-011793-hlktpla4	30	60	patients	patient	NNS
cord-011793-hlktpla4	30	61	,	,	,
cord-011793-hlktpla4	30	62	is	be	VBZ
cord-011793-hlktpla4	30	63	clearly	clearly	RB
cord-011793-hlktpla4	30	64	unacceptable	unacceptable	JJ
cord-011793-hlktpla4	30	65	.	.	.
cord-011793-hlktpla4	31	1	Outcomes	outcome	NNS
cord-011793-hlktpla4	31	2	of	of	IN
cord-011793-hlktpla4	31	3	critically	critically	RB
cord-011793-hlktpla4	31	4	ill	ill	JJ
cord-011793-hlktpla4	31	5	patients	patient	NNS
cord-011793-hlktpla4	31	6	have	have	VBP
cord-011793-hlktpla4	31	7	improved	improve	VBN
cord-011793-hlktpla4	31	8	steadily	steadily	RB
cord-011793-hlktpla4	31	9	over	over	IN
cord-011793-hlktpla4	31	10	the	the	DT
cord-011793-hlktpla4	31	11	last	last	JJ
cord-011793-hlktpla4	31	12	3	3	CD
cord-011793-hlktpla4	31	13	decades	decade	NNS
cord-011793-hlktpla4	31	14	,	,	,
cord-011793-hlktpla4	31	15	not	not	RB
cord-011793-hlktpla4	31	16	through	through	IN
cord-011793-hlktpla4	31	17	the	the	DT
cord-011793-hlktpla4	31	18	approval	approval	NN
cord-011793-hlktpla4	31	19	of	of	IN
cord-011793-hlktpla4	31	20	new	new	JJ
cord-011793-hlktpla4	31	21	pharmacologic	pharmacologic	JJ
cord-011793-hlktpla4	31	22	agents	agent	NNS
cord-011793-hlktpla4	31	23	or	or	CC
cord-011793-hlktpla4	31	24	by	by	IN
cord-011793-hlktpla4	31	25	discovering	discover	VBG
cord-011793-hlktpla4	31	26	some	some	DT
cord-011793-hlktpla4	31	27	unique	unique	JJ
cord-011793-hlktpla4	31	28	physiology	physiology	NN
cord-011793-hlktpla4	31	29	in	in	IN
cord-011793-hlktpla4	31	30	a	a	DT
cord-011793-hlktpla4	31	31	new	new	JJ
cord-011793-hlktpla4	31	32	disease	disease	NN
cord-011793-hlktpla4	31	33	.	.	.
cord-011793-hlktpla4	32	1	Instead	instead	RB
cord-011793-hlktpla4	32	2	,	,	,
cord-011793-hlktpla4	32	3	improved	improved	JJ
cord-011793-hlktpla4	32	4	outcomes	outcome	NNS
cord-011793-hlktpla4	32	5	are	be	VBP
cord-011793-hlktpla4	32	6	seen	see	VBN
cord-011793-hlktpla4	32	7	through	through	IN
cord-011793-hlktpla4	32	8	understanding	understanding	NN
cord-011793-hlktpla4	32	9	and	and	CC
cord-011793-hlktpla4	32	10	implementing	implement	VBG
cord-011793-hlktpla4	32	11	best	good	JJS
cord-011793-hlktpla4	32	12	practices	practice	NNS
cord-011793-hlktpla4	32	13	derived	derive	VBN
cord-011793-hlktpla4	32	14	via	via	IN
cord-011793-hlktpla4	32	15	strong	strong	JJ
cord-011793-hlktpla4	32	16	scientific	scientific	JJ
cord-011793-hlktpla4	32	17	evidence	evidence	NN
cord-011793-hlktpla4	32	18	generated	generate	VBN
cord-011793-hlktpla4	32	19	from	from	IN
cord-011793-hlktpla4	32	20	well	well	RB
cord-011793-hlktpla4	32	21	-	-	HYPH
cord-011793-hlktpla4	32	22	designed	design	VBN
cord-011793-hlktpla4	32	23	randomized	randomized	JJ
cord-011793-hlktpla4	32	24	controlled	control	VBN
cord-011793-hlktpla4	32	25	trials	trial	NNS
cord-011793-hlktpla4	32	26	into	into	IN
cord-011793-hlktpla4	32	27	the	the	DT
cord-011793-hlktpla4	32	28	routine	routine	JJ
cord-011793-hlktpla4	32	29	care	care	NN
cord-011793-hlktpla4	32	30	of	of	IN
cord-011793-hlktpla4	32	31	critically	critically	RB
cord-011793-hlktpla4	32	32	ill	ill	JJ
cord-011793-hlktpla4	32	33	patients	patient	NNS
cord-011793-hlktpla4	32	34	.	.	.
cord-011793-hlktpla4	33	1	In	in	IN
cord-011793-hlktpla4	33	2	other	other	JJ
cord-011793-hlktpla4	33	3	words	word	NNS
cord-011793-hlktpla4	33	4	,	,	,
cord-011793-hlktpla4	33	5	doing	do	VBG
cord-011793-hlktpla4	33	6	the	the	DT
cord-011793-hlktpla4	33	7	things	thing	NNS
cord-011793-hlktpla4	33	8	we	-PRON-	PRP
cord-011793-hlktpla4	33	9	do	do	VBP
cord-011793-hlktpla4	33	10	,	,	,
cord-011793-hlktpla4	33	11	and	and	CC
cord-011793-hlktpla4	33	12	doing	do	VBG
cord-011793-hlktpla4	33	13	them	-PRON-	PRP
cord-011793-hlktpla4	33	14	well	well	RB
cord-011793-hlktpla4	33	15	.	.	.
cord-011793-hlktpla4	34	1	Lung	lung	NN
cord-011793-hlktpla4	34	2	-	-	HYPH
cord-011793-hlktpla4	34	3	protective	protective	JJ
cord-011793-hlktpla4	34	4	ventilation	ventilation	NN
cord-011793-hlktpla4	34	5	with	with	IN
cord-011793-hlktpla4	34	6	lower	low	JJR
cord-011793-hlktpla4	34	7	tidal	tidal	JJ
cord-011793-hlktpla4	34	8	volumes	volume	NNS
cord-011793-hlktpla4	34	9	reduces	reduce	VBZ
cord-011793-hlktpla4	34	10	mortality	mortality	NN
cord-011793-hlktpla4	34	11	and	and	CC
cord-011793-hlktpla4	34	12	shortens	shorten	VBZ
cord-011793-hlktpla4	34	13	duration	duration	NN
cord-011793-hlktpla4	34	14	of	of	IN
cord-011793-hlktpla4	34	15	ventilation	ventilation	NN
cord-011793-hlktpla4	34	16	in	in	IN
cord-011793-hlktpla4	34	17	patients	patient	NNS
cord-011793-hlktpla4	34	18	with	with	IN
cord-011793-hlktpla4	34	19	ARDS	ARDS	NNP
cord-011793-hlktpla4	34	20	(	(	-LRB-
cord-011793-hlktpla4	34	21	10	10	CD
cord-011793-hlktpla4	34	22	)	)	-RRB-
cord-011793-hlktpla4	34	23	,	,	,
cord-011793-hlktpla4	34	24	even	even	RB
cord-011793-hlktpla4	34	25	those	those	DT
cord-011793-hlktpla4	34	26	who	who	WP
cord-011793-hlktpla4	34	27	have	have	VBP
cord-011793-hlktpla4	34	28	relatively	relatively	RB
cord-011793-hlktpla4	34	29	preserved	preserve	VBN
cord-011793-hlktpla4	34	30	compliance	compliance	NN
cord-011793-hlktpla4	34	31	(	(	-LRB-
cord-011793-hlktpla4	34	32	11	11	CD
cord-011793-hlktpla4	34	33	)	)	-RRB-
cord-011793-hlktpla4	34	34	,	,	,
cord-011793-hlktpla4	34	35	like	like	IN
cord-011793-hlktpla4	34	36	that	that	DT
cord-011793-hlktpla4	34	37	being	be	VBG
cord-011793-hlktpla4	34	38	seen	see	VBN
cord-011793-hlktpla4	34	39	early	early	RB
cord-011793-hlktpla4	34	40	in	in	IN
cord-011793-hlktpla4	34	41	the	the	DT
cord-011793-hlktpla4	34	42	ARDS	ARDS	NNP
cord-011793-hlktpla4	34	43	course	course	NN
cord-011793-hlktpla4	34	44	of	of	IN
cord-011793-hlktpla4	34	45	patients	patient	NNS
cord-011793-hlktpla4	34	46	with	with	IN
cord-011793-hlktpla4	34	47	COVID-19	COVID-19	NNP
cord-011793-hlktpla4	34	48	.	.	.
cord-011793-hlktpla4	35	1	In	in	IN
cord-011793-hlktpla4	35	2	addition	addition	NN
cord-011793-hlktpla4	35	3	,	,	,
cord-011793-hlktpla4	35	4	randomized	randomized	JJ
cord-011793-hlktpla4	35	5	trials	trial	NNS
cord-011793-hlktpla4	35	6	in	in	IN
cord-011793-hlktpla4	35	7	ventilated	ventilate	VBN
cord-011793-hlktpla4	35	8	patients	patient	NNS
cord-011793-hlktpla4	35	9	without	without	IN
cord-011793-hlktpla4	35	10	ARDS	ARDS	NNP
cord-011793-hlktpla4	35	11	have	have	VBP
cord-011793-hlktpla4	35	12	also	also	RB
cord-011793-hlktpla4	35	13	demonstrated	demonstrate	VBN
cord-011793-hlktpla4	35	14	improved	improve	VBN
cord-011793-hlktpla4	35	15	outcomes	outcome	NNS
cord-011793-hlktpla4	35	16	with	with	IN
cord-011793-hlktpla4	35	17	similar	similar	JJ
cord-011793-hlktpla4	35	18	lungprotective	lungprotective	JJ
cord-011793-hlktpla4	35	19	ventilation	ventilation	NN
cord-011793-hlktpla4	35	20	strategies	strategy	NNS
cord-011793-hlktpla4	35	21	using	use	VBG
cord-011793-hlktpla4	35	22	tidal	tidal	JJ
cord-011793-hlktpla4	35	23	volumes	volume	NNS
cord-011793-hlktpla4	35	24	around	around	IN
cord-011793-hlktpla4	35	25	6	6	CD
cord-011793-hlktpla4	35	26	ml	ml	NNS
cord-011793-hlktpla4	35	27	/	/	SYM
cord-011793-hlktpla4	35	28	kg	kg	NNS
cord-011793-hlktpla4	35	29	predicted	predict	VBD
cord-011793-hlktpla4	35	30	body	body	NN
cord-011793-hlktpla4	35	31	weight	weight	NN
cord-011793-hlktpla4	35	32	(	(	-LRB-
cord-011793-hlktpla4	35	33	12	12	CD
cord-011793-hlktpla4	35	34	)	)	-RRB-
cord-011793-hlktpla4	35	35	.	.	.
cord-011793-hlktpla4	36	1	Studies	study	NNS
cord-011793-hlktpla4	36	2	demonstrating	demonstrate	VBG
cord-011793-hlktpla4	36	3	benefit	benefit	NN
cord-011793-hlktpla4	36	4	from	from	IN
cord-011793-hlktpla4	36	5	higher	high	JJR
cord-011793-hlktpla4	36	6	tidal	tidal	JJ
cord-011793-hlktpla4	36	7	volumes	volume	NNS
cord-011793-hlktpla4	36	8	in	in	IN
cord-011793-hlktpla4	36	9	patients	patient	NNS
cord-011793-hlktpla4	36	10	with	with	IN
cord-011793-hlktpla4	36	11	higher	high	JJR
cord-011793-hlktpla4	36	12	compliance	compliance	NN
cord-011793-hlktpla4	36	13	are	be	VBP
cord-011793-hlktpla4	36	14	nonexistent	nonexistent	JJ
cord-011793-hlktpla4	36	15	,	,	,
cord-011793-hlktpla4	36	16	and	and	CC
cord-011793-hlktpla4	36	17	to	to	TO
cord-011793-hlktpla4	36	18	think	think	VB
cord-011793-hlktpla4	36	19	that	that	IN
cord-011793-hlktpla4	36	20	after	after	IN
cord-011793-hlktpla4	36	21	a	a	DT
cord-011793-hlktpla4	36	22	few	few	JJ
cord-011793-hlktpla4	36	23	months	month	NNS
cord-011793-hlktpla4	36	24	of	of	IN
cord-011793-hlktpla4	36	25	experience	experience	NN
cord-011793-hlktpla4	36	26	we	-PRON-	PRP
cord-011793-hlktpla4	36	27	have	have	VBP
cord-011793-hlktpla4	36	28	found	find	VBN
cord-011793-hlktpla4	36	29	a	a	DT
cord-011793-hlktpla4	36	30	special	special	JJ
cord-011793-hlktpla4	36	31	population	population	NN
cord-011793-hlktpla4	36	32	that	that	WDT
cord-011793-hlktpla4	36	33	we	-PRON-	PRP
cord-011793-hlktpla4	36	34	should	should	MD
cord-011793-hlktpla4	36	35	ventilate	ventilate	VB
cord-011793-hlktpla4	36	36	differently	differently	RB
cord-011793-hlktpla4	36	37	than	than	IN
cord-011793-hlktpla4	36	38	all	all	DT
cord-011793-hlktpla4	36	39	others	other	NNS
cord-011793-hlktpla4	36	40	seems	seem	VBZ
cord-011793-hlktpla4	36	41	nonsensical	nonsensical	JJ
cord-011793-hlktpla4	36	42	.	.	.
cord-011793-hlktpla4	37	1	Similarly	similarly	RB
cord-011793-hlktpla4	37	2	,	,	,
cord-011793-hlktpla4	37	3	higher	high	JJR
cord-011793-hlktpla4	37	4	levels	level	NNS
cord-011793-hlktpla4	37	5	of	of	IN
cord-011793-hlktpla4	37	6	positive	positive	JJ
cord-011793-hlktpla4	37	7	end	end	NN
cord-011793-hlktpla4	37	8	-	-	HYPH
cord-011793-hlktpla4	37	9	expiratory	expiratory	NN
cord-011793-hlktpla4	37	10	pressure	pressure	NN
cord-011793-hlktpla4	37	11	(	(	-LRB-
cord-011793-hlktpla4	37	12	PEEP	peep	NN
cord-011793-hlktpla4	37	13	)	)	-RRB-
cord-011793-hlktpla4	37	14	(	(	-LRB-
cord-011793-hlktpla4	37	15	13	13	CD
cord-011793-hlktpla4	37	16	)	)	-RRB-
cord-011793-hlktpla4	37	17	and	and	CC
cord-011793-hlktpla4	37	18	prone	prone	JJ
cord-011793-hlktpla4	37	19	positioning	positioning	NN
cord-011793-hlktpla4	37	20	(	(	-LRB-
cord-011793-hlktpla4	37	21	14	14	CD
cord-011793-hlktpla4	37	22	)	)	-RRB-
cord-011793-hlktpla4	37	23	have	have	VBP
cord-011793-hlktpla4	37	24	both	both	DT
cord-011793-hlktpla4	37	25	been	be	VBN
cord-011793-hlktpla4	37	26	demonstrated	demonstrate	VBN
cord-011793-hlktpla4	37	27	to	to	TO
cord-011793-hlktpla4	37	28	improve	improve	VB
cord-011793-hlktpla4	37	29	mortality	mortality	NN
cord-011793-hlktpla4	37	30	in	in	IN
cord-011793-hlktpla4	37	31	patients	patient	NNS
cord-011793-hlktpla4	37	32	with	with	IN
cord-011793-hlktpla4	37	33	severe	severe	JJ
cord-011793-hlktpla4	37	34	ARDS	ARDS	NNP
cord-011793-hlktpla4	37	35	,	,	,
cord-011793-hlktpla4	37	36	as	as	IN
cord-011793-hlktpla4	37	37	defined	define	VBN
cord-011793-hlktpla4	37	38	by	by	IN
cord-011793-hlktpla4	37	39	oxygenation	oxygenation	NN
cord-011793-hlktpla4	37	40	and	and	CC
cord-011793-hlktpla4	37	41	not	not	RB
cord-011793-hlktpla4	37	42	lung	lung	NN
cord-011793-hlktpla4	37	43	compliance	compliance	NN
cord-011793-hlktpla4	37	44	.	.	.
cord-011793-hlktpla4	38	1	Maintaining	maintain	VBG
cord-011793-hlktpla4	38	2	other	other	JJ
cord-011793-hlktpla4	38	3	principles	principle	NNS
cord-011793-hlktpla4	38	4	of	of	IN
cord-011793-hlktpla4	38	5	good	good	JJ
cord-011793-hlktpla4	38	6	critical	critical	JJ
cord-011793-hlktpla4	38	7	care	care	NN
cord-011793-hlktpla4	38	8	,	,	,
cord-011793-hlktpla4	38	9	as	as	IN
cord-011793-hlktpla4	38	10	demonstrated	demonstrate	VBN
cord-011793-hlktpla4	38	11	in	in	IN
cord-011793-hlktpla4	38	12	large	large	JJ
cord-011793-hlktpla4	38	13	,	,	,
cord-011793-hlktpla4	38	14	multicenter	multicenter	JJ
cord-011793-hlktpla4	38	15	randomized	randomized	JJ
cord-011793-hlktpla4	38	16	trials	trial	NNS
cord-011793-hlktpla4	38	17	,	,	,
cord-011793-hlktpla4	38	18	will	will	MD
cord-011793-hlktpla4	38	19	also	also	RB
cord-011793-hlktpla4	38	20	improve	improve	VB
cord-011793-hlktpla4	38	21	outcomes	outcome	NNS
cord-011793-hlktpla4	38	22	in	in	IN
cord-011793-hlktpla4	38	23	these	these	DT
cord-011793-hlktpla4	38	24	critically	critically	RB
cord-011793-hlktpla4	38	25	ill	ill	JJ
cord-011793-hlktpla4	38	26	patients	patient	NNS
cord-011793-hlktpla4	38	27	with	with	IN
cord-011793-hlktpla4	38	28	COVID-19	COVID-19	NNP
cord-011793-hlktpla4	38	29	,	,	,
cord-011793-hlktpla4	38	30	even	even	RB
cord-011793-hlktpla4	38	31	if	if	IN
cord-011793-hlktpla4	38	32	"	"	``
cord-011793-hlktpla4	38	33	COVID-19	COVID-19	NNP
cord-011793-hlktpla4	38	34	is	be	VBZ
cord-011793-hlktpla4	38	35	completely	completely	RB
cord-011793-hlktpla4	38	36	different	different	JJ
cord-011793-hlktpla4	38	37	from	from	IN
cord-011793-hlktpla4	38	38	other	other	JJ
cord-011793-hlktpla4	38	39	intensive	intensive	JJ
cord-011793-hlktpla4	38	40	care	care	NN
cord-011793-hlktpla4	38	41	unit	unit	NN
cord-011793-hlktpla4	38	42	syndromes	syndrome	NNS
cord-011793-hlktpla4	38	43	.	.	.
cord-011793-hlktpla4	39	1	"	"	``
cord-011793-hlktpla4	39	2	Conservative	conservative	JJ
cord-011793-hlktpla4	39	3	fluid	fluid	JJ
cord-011793-hlktpla4	39	4	management	management	NN
cord-011793-hlktpla4	39	5	once	once	RB
cord-011793-hlktpla4	39	6	out	out	IN
cord-011793-hlktpla4	39	7	of	of	IN
cord-011793-hlktpla4	39	8	shock	shock	NN
cord-011793-hlktpla4	39	9	and	and	CC
cord-011793-hlktpla4	39	10	without	without	IN
cord-011793-hlktpla4	39	11	renal	renal	JJ
cord-011793-hlktpla4	39	12	failure	failure	NN
cord-011793-hlktpla4	39	13	increases	increase	VBZ
cord-011793-hlktpla4	39	14	time	time	NN
cord-011793-hlktpla4	39	15	alive	alive	JJ
cord-011793-hlktpla4	39	16	and	and	CC
cord-011793-hlktpla4	39	17	free	free	JJ
cord-011793-hlktpla4	39	18	from	from	IN
cord-011793-hlktpla4	39	19	ventilation	ventilation	NN
cord-011793-hlktpla4	39	20	(	(	-LRB-
cord-011793-hlktpla4	39	21	15	15	CD
cord-011793-hlktpla4	39	22	)	)	-RRB-
cord-011793-hlktpla4	39	23	.	.	.
cord-011793-hlktpla4	40	1	Although	although	IN
cord-011793-hlktpla4	40	2	frequently	frequently	RB
cord-011793-hlktpla4	40	3	more	more	RBR
cord-011793-hlktpla4	40	4	difficult	difficult	JJ
cord-011793-hlktpla4	40	5	in	in	IN
cord-011793-hlktpla4	40	6	these	these	DT
cord-011793-hlktpla4	40	7	patients	patient	NNS
cord-011793-hlktpla4	40	8	,	,	,
cord-011793-hlktpla4	40	9	concurrently	concurrently	RB
cord-011793-hlktpla4	40	10	timed	time	VBN
cord-011793-hlktpla4	40	11	daily	daily	JJ
cord-011793-hlktpla4	40	12	awakening	awakening	NN
cord-011793-hlktpla4	40	13	and	and	CC
cord-011793-hlktpla4	40	14	spontaneous	spontaneous	JJ
cord-011793-hlktpla4	40	15	breathing	breathing	NN
cord-011793-hlktpla4	40	16	trials	trial	NNS
cord-011793-hlktpla4	40	17	,	,	,
cord-011793-hlktpla4	40	18	with	with	IN
cord-011793-hlktpla4	40	19	close	close	JJ
cord-011793-hlktpla4	40	20	monitoring	monitoring	NN
cord-011793-hlktpla4	40	21	at	at	IN
cord-011793-hlktpla4	40	22	the	the	DT
cord-011793-hlktpla4	40	23	patients	patient	NNS
cord-011793-hlktpla4	40	24	'	'	POS
cord-011793-hlktpla4	40	25	bedside	bedside	NN
cord-011793-hlktpla4	40	26	and	and	CC
cord-011793-hlktpla4	40	27	efficient	efficient	JJ
cord-011793-hlktpla4	40	28	extubation	extubation	NN
cord-011793-hlktpla4	40	29	after	after	IN
cord-011793-hlktpla4	40	30	30	30	CD
cord-011793-hlktpla4	40	31	minutes	minute	NNS
cord-011793-hlktpla4	40	32	,	,	,
cord-011793-hlktpla4	40	33	sometimes	sometimes	RB
cord-011793-hlktpla4	40	34	using	use	VBG
cord-011793-hlktpla4	40	35	low	low	JJ
cord-011793-hlktpla4	40	36	-	-	HYPH
cord-011793-hlktpla4	40	37	dose	dose	NN
cord-011793-hlktpla4	40	38	dexmedetomidine	dexmedetomidine	NN
cord-011793-hlktpla4	40	39	,	,	,
cord-011793-hlktpla4	40	40	can	can	MD
cord-011793-hlktpla4	40	41	successfully	successfully	RB
cord-011793-hlktpla4	40	42	liberate	liberate	VB
cord-011793-hlktpla4	40	43	these	these	DT
cord-011793-hlktpla4	40	44	patients	patient	NNS
cord-011793-hlktpla4	40	45	from	from	IN
cord-011793-hlktpla4	40	46	the	the	DT
cord-011793-hlktpla4	40	47	ventilator	ventilator	NN
cord-011793-hlktpla4	40	48	faster	fast	RBR
cord-011793-hlktpla4	40	49	(	(	-LRB-
cord-011793-hlktpla4	40	50	16	16	CD
cord-011793-hlktpla4	40	51	)	)	-RRB-
cord-011793-hlktpla4	40	52	,	,	,
cord-011793-hlktpla4	40	53	making	make	VBG
cord-011793-hlktpla4	40	54	that	that	DT
cord-011793-hlktpla4	40	55	ventilator	ventilator	NN
cord-011793-hlktpla4	40	56	available	available	JJ
cord-011793-hlktpla4	40	57	for	for	IN
cord-011793-hlktpla4	40	58	the	the	DT
cord-011793-hlktpla4	40	59	next	next	JJ
cord-011793-hlktpla4	40	60	critically	critically	RB
cord-011793-hlktpla4	40	61	ill	ill	JJ
cord-011793-hlktpla4	40	62	patient	patient	NN
cord-011793-hlktpla4	40	63	.	.	.
cord-011793-hlktpla4	41	1	Checklists	checklist	NNS
cord-011793-hlktpla4	41	2	for	for	IN
cord-011793-hlktpla4	41	3	placement	placement	NN
cord-011793-hlktpla4	41	4	of	of	IN
cord-011793-hlktpla4	41	5	central	central	JJ
cord-011793-hlktpla4	41	6	lines	line	NNS
cord-011793-hlktpla4	41	7	(	(	-LRB-
cord-011793-hlktpla4	41	8	17	17	CD
cord-011793-hlktpla4	41	9	)	)	-RRB-
cord-011793-hlktpla4	41	10	and	and	CC
cord-011793-hlktpla4	41	11	other	other	JJ
cord-011793-hlktpla4	41	12	infection	infection	NN
cord-011793-hlktpla4	41	13	prevention	prevention	NN
cord-011793-hlktpla4	41	14	strategies	strategy	NNS
cord-011793-hlktpla4	41	15	will	will	MD
cord-011793-hlktpla4	41	16	decrease	decrease	VB
cord-011793-hlktpla4	41	17	health	health	NN
cord-011793-hlktpla4	41	18	care	care	NN
cord-011793-hlktpla4	41	19	-	-	HYPH
cord-011793-hlktpla4	41	20	acquired	acquire	VBN
cord-011793-hlktpla4	41	21	infections	infection	NNS
cord-011793-hlktpla4	41	22	and	and	CC
cord-011793-hlktpla4	41	23	reduce	reduce	VB
cord-011793-hlktpla4	41	24	length	length	NN
cord-011793-hlktpla4	41	25	of	of	IN
cord-011793-hlktpla4	41	26	stay	stay	NN
cord-011793-hlktpla4	41	27	.	.	.
cord-011793-hlktpla4	42	1	Many	many	JJ
cord-011793-hlktpla4	42	2	have	have	VBP
cord-011793-hlktpla4	42	3	recommended	recommend	VBN
cord-011793-hlktpla4	42	4	avoiding	avoid	VBG
cord-011793-hlktpla4	42	5	noninvasive	noninvasive	JJ
cord-011793-hlktpla4	42	6	ventilation	ventilation	NN
cord-011793-hlktpla4	42	7	or	or	CC
cord-011793-hlktpla4	42	8	high	high	JJ
cord-011793-hlktpla4	42	9	-	-	HYPH
cord-011793-hlktpla4	42	10	flow	flow	NN
cord-011793-hlktpla4	42	11	nasal	nasal	NN
cord-011793-hlktpla4	42	12	cannula	cannula	NN
cord-011793-hlktpla4	42	13	because	because	IN
cord-011793-hlktpla4	42	14	of	of	IN
cord-011793-hlktpla4	42	15	risk	risk	NN
cord-011793-hlktpla4	42	16	of	of	IN
cord-011793-hlktpla4	42	17	increasing	increase	VBG
cord-011793-hlktpla4	42	18	aerosolization	aerosolization	NN
cord-011793-hlktpla4	42	19	(	(	-LRB-
cord-011793-hlktpla4	42	20	18	18	CD
cord-011793-hlktpla4	42	21	)	)	-RRB-
cord-011793-hlktpla4	42	22	.	.	.
cord-011793-hlktpla4	43	1	However	however	RB
cord-011793-hlktpla4	43	2	,	,	,
cord-011793-hlktpla4	43	3	these	these	DT
cord-011793-hlktpla4	43	4	recommendations	recommendation	NNS
cord-011793-hlktpla4	43	5	fail	fail	VBP
cord-011793-hlktpla4	43	6	to	to	TO
cord-011793-hlktpla4	43	7	reference	reference	VB
cord-011793-hlktpla4	43	8	any	any	DT
cord-011793-hlktpla4	43	9	studies	study	NNS
cord-011793-hlktpla4	43	10	or	or	CC
cord-011793-hlktpla4	43	11	supporting	support	VBG
cord-011793-hlktpla4	43	12	data	datum	NNS
cord-011793-hlktpla4	43	13	demonstrating	demonstrate	VBG
cord-011793-hlktpla4	43	14	this	this	DT
cord-011793-hlktpla4	43	15	to	to	TO
cord-011793-hlktpla4	43	16	be	be	VB
cord-011793-hlktpla4	43	17	the	the	DT
cord-011793-hlktpla4	43	18	case	case	NN
cord-011793-hlktpla4	43	19	in	in	IN
cord-011793-hlktpla4	43	20	patients	patient	NNS
cord-011793-hlktpla4	43	21	with	with	IN
cord-011793-hlktpla4	43	22	COVID-19	COVID-19	NNP
cord-011793-hlktpla4	43	23	and	and	CC
cord-011793-hlktpla4	43	24	are	be	VBP
cord-011793-hlktpla4	43	25	contrary	contrary	JJ
cord-011793-hlktpla4	43	26	to	to	IN
cord-011793-hlktpla4	43	27	both	both	PDT
cord-011793-hlktpla4	43	28	the	the	DT
cord-011793-hlktpla4	43	29	Surviving	Surviving	NNP
cord-011793-hlktpla4	43	30	Sepsis	Sepsis	NNP
cord-011793-hlktpla4	43	31	Campaign	Campaign	NNP
cord-011793-hlktpla4	43	32	(	(	-LRB-
cord-011793-hlktpla4	43	33	19	19	CD
cord-011793-hlktpla4	43	34	)	)	-RRB-
cord-011793-hlktpla4	43	35	and	and	CC
cord-011793-hlktpla4	43	36	Australian	australian	JJ
cord-011793-hlktpla4	43	37	and	and	CC
cord-011793-hlktpla4	43	38	New	New	NNP
cord-011793-hlktpla4	43	39	Zealand	Zealand	NNP
cord-011793-hlktpla4	43	40	Intensive	Intensive	NNP
cord-011793-hlktpla4	43	41	Care	Care	NNP
cord-011793-hlktpla4	43	42	Society	Society	NNP
cord-011793-hlktpla4	43	43	Guidelines	Guidelines	NNPS
cord-011793-hlktpla4	43	44	(	(	-LRB-
cord-011793-hlktpla4	43	45	20	20	CD
cord-011793-hlktpla4	43	46	)	)	-RRB-
cord-011793-hlktpla4	43	47	for	for	IN
cord-011793-hlktpla4	43	48	treating	treat	VBG
cord-011793-hlktpla4	43	49	COVID-19	covid-19	CD
cord-011793-hlktpla4	43	50	,	,	,
cord-011793-hlktpla4	43	51	both	both	DT
cord-011793-hlktpla4	43	52	of	of	IN
cord-011793-hlktpla4	43	53	which	which	WDT
cord-011793-hlktpla4	43	54	recommend	recommend	VBP
cord-011793-hlktpla4	43	55	using	use	VBG
cord-011793-hlktpla4	43	56	these	these	DT
cord-011793-hlktpla4	43	57	devices	device	NNS
cord-011793-hlktpla4	43	58	.	.	.
cord-011793-hlktpla4	44	1	Changing	change	VBG
cord-011793-hlktpla4	44	2	practice	practice	NN
cord-011793-hlktpla4	44	3	to	to	TO
cord-011793-hlktpla4	44	4	avoid	avoid	VB
cord-011793-hlktpla4	44	5	these	these	DT
cord-011793-hlktpla4	44	6	oxygen	oxygen	NN
cord-011793-hlktpla4	44	7	-	-	HYPH
cord-011793-hlktpla4	44	8	delivery	delivery	NN
cord-011793-hlktpla4	44	9	devices	device	NNS
cord-011793-hlktpla4	44	10	has	have	VBZ
cord-011793-hlktpla4	44	11	dramatically	dramatically	RB
cord-011793-hlktpla4	44	12	altered	alter	VBN
cord-011793-hlktpla4	44	13	the	the	DT
cord-011793-hlktpla4	44	14	care	care	NN
cord-011793-hlktpla4	44	15	of	of	IN
cord-011793-hlktpla4	44	16	patients	patient	NNS
cord-011793-hlktpla4	44	17	with	with	IN
cord-011793-hlktpla4	44	18	COVID-19	COVID-19	NNP
cord-011793-hlktpla4	44	19	,	,	,
cord-011793-hlktpla4	44	20	potentially	potentially	RB
cord-011793-hlktpla4	44	21	to	to	IN
cord-011793-hlktpla4	44	22	their	-PRON-	PRP$
cord-011793-hlktpla4	44	23	detriment	detriment	NN
cord-011793-hlktpla4	44	24	(	(	-LRB-
cord-011793-hlktpla4	44	25	21	21	CD
cord-011793-hlktpla4	44	26	)	)	-RRB-
cord-011793-hlktpla4	44	27	.	.	.
cord-011793-hlktpla4	45	1	In	in	IN
cord-011793-hlktpla4	45	2	a	a	DT
cord-011793-hlktpla4	45	3	pandemic	pandemic	NN
cord-011793-hlktpla4	45	4	that	that	WDT
cord-011793-hlktpla4	45	5	is	be	VBZ
cord-011793-hlktpla4	45	6	projected	project	VBN
cord-011793-hlktpla4	45	7	to	to	TO
cord-011793-hlktpla4	45	8	sicken	sicken	VB
cord-011793-hlktpla4	45	9	millions	million	NNS
cord-011793-hlktpla4	45	10	and	and	CC
cord-011793-hlktpla4	45	11	cause	cause	VB
cord-011793-hlktpla4	45	12	acute	acute	JJ
cord-011793-hlktpla4	45	13	respiratory	respiratory	JJ
cord-011793-hlktpla4	45	14	failure	failure	NN
cord-011793-hlktpla4	45	15	and	and	CC
cord-011793-hlktpla4	45	16	critical	critical	JJ
cord-011793-hlktpla4	45	17	illness	illness	NN
cord-011793-hlktpla4	45	18	in	in	IN
cord-011793-hlktpla4	45	19	tens	ten	NNS
cord-011793-hlktpla4	45	20	or	or	CC
cord-011793-hlktpla4	45	21	hundreds	hundred	NNS
cord-011793-hlktpla4	45	22	of	of	IN
cord-011793-hlktpla4	45	23	thousands	thousand	NNS
cord-011793-hlktpla4	45	24	,	,	,
cord-011793-hlktpla4	45	25	removing	remove	VBG
cord-011793-hlktpla4	45	26	evidence	evidence	NN
cord-011793-hlktpla4	45	27	-	-	HYPH
cord-011793-hlktpla4	45	28	based	base	VBN
cord-011793-hlktpla4	45	29	respiratory	respiratory	JJ
cord-011793-hlktpla4	45	30	support	support	NN
cord-011793-hlktpla4	45	31	devices	device	NNS
cord-011793-hlktpla4	45	32	entirely	entirely	RB
cord-011793-hlktpla4	45	33	from	from	IN
cord-011793-hlktpla4	45	34	our	-PRON-	PRP$
cord-011793-hlktpla4	45	35	arsenal	arsenal	NN
cord-011793-hlktpla4	45	36	of	of	IN
cord-011793-hlktpla4	45	37	weapons	weapon	NNS
cord-011793-hlktpla4	45	38	to	to	TO
cord-011793-hlktpla4	45	39	fight	fight	VB
cord-011793-hlktpla4	45	40	COVID-19	COVID-19	NNP
cord-011793-hlktpla4	45	41	and	and	CC
cord-011793-hlktpla4	45	42	intubating	intubate	VBG
cord-011793-hlktpla4	45	43	everyone	everyone	NN
cord-011793-hlktpla4	45	44	"	"	``
cord-011793-hlktpla4	45	45	early	early	JJ
cord-011793-hlktpla4	45	46	"	"	''
cord-011793-hlktpla4	45	47	will	will	MD
cord-011793-hlktpla4	45	48	certainly	certainly	RB
cord-011793-hlktpla4	45	49	result	result	VB
cord-011793-hlktpla4	45	50	in	in	IN
cord-011793-hlktpla4	45	51	a	a	DT
cord-011793-hlktpla4	45	52	losing	lose	VBG
cord-011793-hlktpla4	45	53	battle	battle	NN
cord-011793-hlktpla4	45	54	.	.	.
cord-011793-hlktpla4	46	1	ICU	ICU	NNP
cord-011793-hlktpla4	46	2	capacity	capacity	NN
cord-011793-hlktpla4	46	3	,	,	,
cord-011793-hlktpla4	46	4	ventilator	ventilator	NN
cord-011793-hlktpla4	46	5	supplies	supply	NNS
cord-011793-hlktpla4	46	6	,	,	,
cord-011793-hlktpla4	46	7	and	and	CC
cord-011793-hlktpla4	46	8	survival	survival	NN
cord-011793-hlktpla4	46	9	during	during	IN
cord-011793-hlktpla4	46	10	the	the	DT
cord-011793-hlktpla4	46	11	COVID-19	COVID-19	NNP
cord-011793-hlktpla4	46	12	pandemic	pandemic	NN
cord-011793-hlktpla4	46	13	could	could	MD
cord-011793-hlktpla4	46	14	all	all	RB
cord-011793-hlktpla4	46	15	be	be	VB
cord-011793-hlktpla4	46	16	increased	increase	VBN
cord-011793-hlktpla4	46	17	today	today	NN
cord-011793-hlktpla4	46	18	if	if	IN
cord-011793-hlktpla4	46	19	the	the	DT
cord-011793-hlktpla4	46	20	critical	critical	JJ
cord-011793-hlktpla4	46	21	care	care	NN
cord-011793-hlktpla4	46	22	community	community	NN
cord-011793-hlktpla4	46	23	practiced	practice	VBD
cord-011793-hlktpla4	46	24	the	the	DT
cord-011793-hlktpla4	46	25	evidenced	evidence	VBN
cord-011793-hlktpla4	46	26	-	-	HYPH
cord-011793-hlktpla4	46	27	based	base	VBN
cord-011793-hlktpla4	46	28	principles	principle	NNS
cord-011793-hlktpla4	46	29	discovered	discover	VBN
cord-011793-hlktpla4	46	30	over	over	IN
cord-011793-hlktpla4	46	31	the	the	DT
cord-011793-hlktpla4	46	32	last	last	JJ
cord-011793-hlktpla4	46	33	3	3	CD
cord-011793-hlktpla4	46	34	decades	decade	NNS
cord-011793-hlktpla4	46	35	.	.	.
cord-011793-hlktpla4	47	1	Innumerable	innumerable	JJ
cord-011793-hlktpla4	47	2	randomized	randomized	JJ
cord-011793-hlktpla4	47	3	controlled	control	VBN
cord-011793-hlktpla4	47	4	trials	trial	NNS
cord-011793-hlktpla4	47	5	have	have	VBP
cord-011793-hlktpla4	47	6	produced	produce	VBN
cord-011793-hlktpla4	47	7	the	the	DT
cord-011793-hlktpla4	47	8	robust	robust	JJ
cord-011793-hlktpla4	47	9	knowledge	knowledge	NN
cord-011793-hlktpla4	47	10	necessary	necessary	JJ
cord-011793-hlktpla4	47	11	to	to	TO
cord-011793-hlktpla4	47	12	care	care	VB
cord-011793-hlktpla4	47	13	for	for	IN
cord-011793-hlktpla4	47	14	patients	patient	NNS
cord-011793-hlktpla4	47	15	with	with	IN
cord-011793-hlktpla4	47	16	COVID-19	covid-19	DT
cord-011793-hlktpla4	47	17	while	while	IN
cord-011793-hlktpla4	47	18	we	-PRON-	PRP
cord-011793-hlktpla4	47	19	await	await	VBP
cord-011793-hlktpla4	47	20	high	high	JJ
cord-011793-hlktpla4	47	21	-	-	HYPH
cord-011793-hlktpla4	47	22	quality	quality	NN
cord-011793-hlktpla4	47	23	evidence	evidence	NN
cord-011793-hlktpla4	47	24	of	of	IN
cord-011793-hlktpla4	47	25	whether	whether	IN
cord-011793-hlktpla4	47	26	any	any	DT
cord-011793-hlktpla4	47	27	new	new	JJ
cord-011793-hlktpla4	47	28	therapies	therapy	NNS
cord-011793-hlktpla4	47	29	improve	improve	VBP
cord-011793-hlktpla4	47	30	outcomes	outcome	NNS
cord-011793-hlktpla4	47	31	.	.	.
cord-011793-hlktpla4	48	1	Improving	improve	VBG
cord-011793-hlktpla4	48	2	capacity	capacity	NN
cord-011793-hlktpla4	48	3	and	and	CC
cord-011793-hlktpla4	48	4	survival	survival	NN
cord-011793-hlktpla4	48	5	will	will	MD
cord-011793-hlktpla4	48	6	be	be	VB
cord-011793-hlktpla4	48	7	accomplished	accomplish	VBN
cord-011793-hlktpla4	48	8	by	by	IN
cord-011793-hlktpla4	48	9	using	use	VBG
cord-011793-hlktpla4	48	10	noninvasive	noninvasive	JJ
cord-011793-hlktpla4	48	11	ventilation	ventilation	NN
cord-011793-hlktpla4	48	12	or	or	CC
cord-011793-hlktpla4	48	13	high	high	JJ
cord-011793-hlktpla4	48	14	-	-	HYPH
cord-011793-hlktpla4	48	15	flow	flow	NN
cord-011793-hlktpla4	48	16	nasal	nasal	NN
cord-011793-hlktpla4	48	17	cannulas	cannula	NNS
cord-011793-hlktpla4	48	18	to	to	TO
cord-011793-hlktpla4	48	19	prevent	prevent	VB
cord-011793-hlktpla4	48	20	intubation	intubation	NN
cord-011793-hlktpla4	48	21	or	or	CC
cord-011793-hlktpla4	48	22	reintubation	reintubation	NN
cord-011793-hlktpla4	48	23	.	.	.
cord-011793-hlktpla4	49	1	In	in	IN
cord-011793-hlktpla4	49	2	the	the	DT
cord-011793-hlktpla4	49	3	intubated	intubate	VBN
cord-011793-hlktpla4	49	4	patient	patient	NN
cord-011793-hlktpla4	49	5	,	,	,
cord-011793-hlktpla4	49	6	the	the	DT
cord-011793-hlktpla4	49	7	use	use	NN
cord-011793-hlktpla4	49	8	of	of	IN
cord-011793-hlktpla4	49	9	lung	lung	NN
cord-011793-hlktpla4	49	10	-	-	HYPH
cord-011793-hlktpla4	49	11	protective	protective	JJ
cord-011793-hlktpla4	49	12	ventilation	ventilation	NN
cord-011793-hlktpla4	49	13	,	,	,
cord-011793-hlktpla4	49	14	PEEP	peep	NN
cord-011793-hlktpla4	49	15	,	,	,
cord-011793-hlktpla4	49	16	prone	prone	JJ
cord-011793-hlktpla4	49	17	positioning	positioning	NN
cord-011793-hlktpla4	49	18	if	if	IN
cord-011793-hlktpla4	49	19	needed	need	VBN
cord-011793-hlktpla4	49	20	,	,	,
cord-011793-hlktpla4	49	21	a	a	DT
cord-011793-hlktpla4	49	22	conservative	conservative	JJ
cord-011793-hlktpla4	49	23	fluid	fluid	JJ
cord-011793-hlktpla4	49	24	-	-	HYPH
cord-011793-hlktpla4	49	25	management	management	NN
cord-011793-hlktpla4	49	26	strategy	strategy	NN
cord-011793-hlktpla4	49	27	,	,	,
cord-011793-hlktpla4	49	28	and	and	CC
cord-011793-hlktpla4	49	29	paired	pair	VBN
cord-011793-hlktpla4	49	30	awakening	awakening	NN
cord-011793-hlktpla4	49	31	and	and	CC
cord-011793-hlktpla4	49	32	spontaneous	spontaneous	JJ
cord-011793-hlktpla4	49	33	breathing	breathing	NN
cord-011793-hlktpla4	49	34	trials	trial	NNS
cord-011793-hlktpla4	49	35	have	have	VBP
cord-011793-hlktpla4	49	36	all	all	DT
cord-011793-hlktpla4	49	37	been	be	VBN
cord-011793-hlktpla4	49	38	shown	show	VBN
cord-011793-hlktpla4	49	39	to	to	TO
cord-011793-hlktpla4	49	40	improve	improve	VB
cord-011793-hlktpla4	49	41	outcomes	outcome	NNS
cord-011793-hlktpla4	49	42	.	.	.
cord-011793-hlktpla4	50	1	In	in	IN
cord-011793-hlktpla4	50	2	this	this	DT
cord-011793-hlktpla4	50	3	time	time	NN
cord-011793-hlktpla4	50	4	of	of	IN
cord-011793-hlktpla4	50	5	increased	increase	VBN
cord-011793-hlktpla4	50	6	work	work	NN
cord-011793-hlktpla4	50	7	and	and	CC
cord-011793-hlktpla4	50	8	uncertainty	uncertainty	NN
cord-011793-hlktpla4	50	9	,	,	,
cord-011793-hlktpla4	50	10	many	many	JJ
cord-011793-hlktpla4	50	11	have	have	VBP
cord-011793-hlktpla4	50	12	forgotten	forget	VBN
cord-011793-hlktpla4	50	13	everything	everything	NN
cord-011793-hlktpla4	50	14	that	that	WDT
cord-011793-hlktpla4	50	15	we	-PRON-	PRP
cord-011793-hlktpla4	50	16	do	do	VBP
cord-011793-hlktpla4	50	17	for	for	IN
cord-011793-hlktpla4	50	18	our	-PRON-	PRP$
cord-011793-hlktpla4	50	19	critically	critically	RB
cord-011793-hlktpla4	50	20	ill	ill	JJ
cord-011793-hlktpla4	50	21	patients	patient	NNS
cord-011793-hlktpla4	50	22	.	.	.
cord-011793-hlktpla4	51	1	Hopefully	hopefully	RB
cord-011793-hlktpla4	51	2	,	,	,
cord-011793-hlktpla4	51	3	this	this	DT
cord-011793-hlktpla4	51	4	is	be	VBZ
cord-011793-hlktpla4	51	5	because	because	IN
cord-011793-hlktpla4	51	6	we	-PRON-	PRP
cord-011793-hlktpla4	51	7	do	do	VBP
cord-011793-hlktpla4	51	8	it	-PRON-	PRP
cord-011793-hlktpla4	51	9	so	so	RB
cord-011793-hlktpla4	51	10	often	often	RB
cord-011793-hlktpla4	51	11	that	that	IN
cord-011793-hlktpla4	51	12	it	-PRON-	PRP
cord-011793-hlktpla4	51	13	becomes	become	VBZ
cord-011793-hlktpla4	51	14	second	second	JJ
cord-011793-hlktpla4	51	15	nature	nature	NN
cord-011793-hlktpla4	51	16	and	and	CC
cord-011793-hlktpla4	51	17	therefore	therefore	RB
cord-011793-hlktpla4	51	18	is	be	VBZ
cord-011793-hlktpla4	51	19	not	not	RB
cord-011793-hlktpla4	51	20	thought	think	VBN
cord-011793-hlktpla4	51	21	of	of	IN
cord-011793-hlktpla4	51	22	as	as	IN
cord-011793-hlktpla4	51	23	special	special	JJ
cord-011793-hlktpla4	51	24	treatment	treatment	NN
cord-011793-hlktpla4	51	25	.	.	.
cord-011793-hlktpla4	52	1	However	however	RB
cord-011793-hlktpla4	52	2	,	,	,
cord-011793-hlktpla4	52	3	potentially	potentially	RB
cord-011793-hlktpla4	52	4	worse	bad	JJR
cord-011793-hlktpla4	52	5	,	,	,
cord-011793-hlktpla4	52	6	practitioners	practitioner	NNS
cord-011793-hlktpla4	52	7	may	may	MD
cord-011793-hlktpla4	52	8	not	not	RB
cord-011793-hlktpla4	52	9	have	have	VB
cord-011793-hlktpla4	52	10	forgotten	forget	VBN
cord-011793-hlktpla4	52	11	but	but	CC
cord-011793-hlktpla4	52	12	may	may	MD
cord-011793-hlktpla4	52	13	be	be	VB
cord-011793-hlktpla4	52	14	purposefully	purposefully	RB
cord-011793-hlktpla4	52	15	treating	treat	VBG
cord-011793-hlktpla4	52	16	patients	patient	NNS
cord-011793-hlktpla4	52	17	differently	differently	RB
cord-011793-hlktpla4	52	18	in	in	IN
cord-011793-hlktpla4	52	19	their	-PRON-	PRP$
cord-011793-hlktpla4	52	20	desire	desire	NN
cord-011793-hlktpla4	52	21	to	to	TO
cord-011793-hlktpla4	52	22	feel	feel	VB
cord-011793-hlktpla4	52	23	like	like	IN
cord-011793-hlktpla4	52	24	they	-PRON-	PRP
cord-011793-hlktpla4	52	25	"	"	``
cord-011793-hlktpla4	52	26	are	be	VBP
cord-011793-hlktpla4	52	27	doing	do	VBG
cord-011793-hlktpla4	52	28	something	something	NN
cord-011793-hlktpla4	52	29	.	.	.
cord-011793-hlktpla4	52	30	"	"	''
cord-011793-hlktpla4	53	1	Not	not	RB
cord-011793-hlktpla4	53	2	giving	give	VBG
cord-011793-hlktpla4	53	3	a	a	DT
cord-011793-hlktpla4	53	4	medication	medication	NN
cord-011793-hlktpla4	53	5	lacking	lack	VBG
cord-011793-hlktpla4	53	6	high	high	JJ
cord-011793-hlktpla4	53	7	-	-	HYPH
cord-011793-hlktpla4	53	8	quality	quality	NN
cord-011793-hlktpla4	53	9	evidence	evidence	NN
cord-011793-hlktpla4	53	10	of	of	IN
cord-011793-hlktpla4	53	11	benefit	benefit	NN
cord-011793-hlktpla4	53	12	does	do	VBZ
cord-011793-hlktpla4	53	13	not	not	RB
cord-011793-hlktpla4	53	14	equal	equal	VB
cord-011793-hlktpla4	53	15	just	just	RB
cord-011793-hlktpla4	53	16	standing	stand	VBG
cord-011793-hlktpla4	53	17	there	there	RB
cord-011793-hlktpla4	53	18	and	and	CC
cord-011793-hlktpla4	53	19	doing	do	VBG
cord-011793-hlktpla4	53	20	nothing	nothing	NN
cord-011793-hlktpla4	53	21	.	.	.
cord-011793-hlktpla4	54	1	To	to	IN
cord-011793-hlktpla4	54	2	the	the	DT
cord-011793-hlktpla4	54	3	contrary	contrary	NN
cord-011793-hlktpla4	54	4	,	,	,
cord-011793-hlktpla4	54	5	providing	provide	VBG
cord-011793-hlktpla4	54	6	evidence	evidence	NN
cord-011793-hlktpla4	54	7	-	-	HYPH
cord-011793-hlktpla4	54	8	based	base	VBN
cord-011793-hlktpla4	54	9	critical	critical	JJ
cord-011793-hlktpla4	54	10	care	care	NN
cord-011793-hlktpla4	54	11	is	be	VBZ
cord-011793-hlktpla4	54	12	more	more	JJR
cord-011793-hlktpla4	54	13	than	than	IN
cord-011793-hlktpla4	54	14	just	just	RB
cord-011793-hlktpla4	54	15	doing	do	VBG
cord-011793-hlktpla4	54	16	something	something	NN
cord-011793-hlktpla4	54	17	for	for	IN
cord-011793-hlktpla4	54	18	our	-PRON-	PRP$
cord-011793-hlktpla4	54	19	patients	patient	NNS
cord-011793-hlktpla4	54	20	.	.	.
cord-011793-hlktpla4	55	1	It	-PRON-	PRP
cord-011793-hlktpla4	55	2	is	be	VBZ
cord-011793-hlktpla4	55	3	providing	provide	VBG
cord-011793-hlktpla4	55	4	them	-PRON-	PRP
cord-011793-hlktpla4	55	5	with	with	IN
cord-011793-hlktpla4	55	6	the	the	DT
cord-011793-hlktpla4	55	7	best	good	JJS
cord-011793-hlktpla4	55	8	possible	possible	JJ
cord-011793-hlktpla4	55	9	chance	chance	NN
cord-011793-hlktpla4	55	10	of	of	IN
cord-011793-hlktpla4	55	11	surviving	survive	VBG
cord-011793-hlktpla4	55	12	without	without	IN
cord-011793-hlktpla4	55	13	complications	complication	NNS
cord-011793-hlktpla4	55	14	and	and	CC
cord-011793-hlktpla4	55	15	not	not	RB
cord-011793-hlktpla4	55	16	putting	put	VBG
cord-011793-hlktpla4	55	17	them	-PRON-	PRP
cord-011793-hlktpla4	55	18	at	at	IN
cord-011793-hlktpla4	55	19	risk	risk	NN
cord-011793-hlktpla4	55	20	for	for	IN
cord-011793-hlktpla4	55	21	poor	poor	JJ
cord-011793-hlktpla4	55	22	outcomes	outcome	NNS
cord-011793-hlktpla4	55	23	from	from	IN
cord-011793-hlktpla4	55	24	non	non	JJ
cord-011793-hlktpla4	55	25	-	-	JJ
cord-011793-hlktpla4	55	26	evidencebased	evidencebased	JJ
cord-011793-hlktpla4	55	27	care	care	NN
cord-011793-hlktpla4	55	28	.	.	.
cord-011793-hlktpla4	55	29	"	"	''
cord-011793-hlktpla4	56	1	Fortune	fortune	NN
cord-011793-hlktpla4	56	2	favors	favor	VBZ
cord-011793-hlktpla4	56	3	the	the	DT
cord-011793-hlktpla4	56	4	bold	bold	JJ
cord-011793-hlktpla4	56	5	,	,	,
cord-011793-hlktpla4	56	6	"	"	''
cord-011793-hlktpla4	56	7	and	and	CC
cord-011793-hlktpla4	56	8	we	-PRON-	PRP
cord-011793-hlktpla4	56	9	should	should	MD
cord-011793-hlktpla4	56	10	boldly	boldly	RB
cord-011793-hlktpla4	56	11	institute	institute	VB
cord-011793-hlktpla4	56	12	the	the	DT
cord-011793-hlktpla4	56	13	evidencebased	evidencebased	JJ
cord-011793-hlktpla4	56	14	medicine	medicine	NN
cord-011793-hlktpla4	56	15	we	-PRON-	PRP
cord-011793-hlktpla4	56	16	have	have	VBP
cord-011793-hlktpla4	56	17	been	be	VBN
cord-011793-hlktpla4	56	18	taught	teach	VBN
cord-011793-hlktpla4	56	19	by	by	IN
cord-011793-hlktpla4	56	20	the	the	DT
cord-011793-hlktpla4	56	21	physician	physician	NN
cord-011793-hlktpla4	56	22	,	,	,
cord-011793-hlktpla4	56	23	nursing	nursing	NN
cord-011793-hlktpla4	56	24	,	,	,
cord-011793-hlktpla4	56	25	and	and	CC
cord-011793-hlktpla4	56	26	respiratory	respiratory	JJ
cord-011793-hlktpla4	56	27	therapy	therapy	NN
cord-011793-hlktpla4	56	28	giants	giant	NNS
cord-011793-hlktpla4	56	29	that	that	WDT
cord-011793-hlktpla4	56	30	have	have	VBP
cord-011793-hlktpla4	56	31	come	come	VBN
cord-011793-hlktpla4	56	32	before	before	IN
cord-011793-hlktpla4	56	33	us	-PRON-	PRP
cord-011793-hlktpla4	56	34	.	.	.
cord-011793-hlktpla4	57	1	It	-PRON-	PRP
cord-011793-hlktpla4	57	2	is	be	VBZ
cord-011793-hlktpla4	57	3	our	-PRON-	PRP$
cord-011793-hlktpla4	57	4	obligation	obligation	NN
cord-011793-hlktpla4	57	5	,	,	,
cord-011793-hlktpla4	57	6	what	what	WP
cord-011793-hlktpla4	57	7	our	-PRON-	PRP$
cord-011793-hlktpla4	57	8	patients	patient	NNS
cord-011793-hlktpla4	57	9	expect	expect	VBP
cord-011793-hlktpla4	57	10	from	from	IN
cord-011793-hlktpla4	57	11	us	-PRON-	PRP
cord-011793-hlktpla4	57	12	,	,	,
cord-011793-hlktpla4	57	13	and	and	CC
cord-011793-hlktpla4	57	14	exactly	exactly	RB
cord-011793-hlktpla4	57	15	what	what	WP
cord-011793-hlktpla4	57	16	we	-PRON-	PRP
cord-011793-hlktpla4	57	17	owe	owe	VBP
cord-011793-hlktpla4	57	18	them	-PRON-	PRP
cord-011793-hlktpla4	57	19	.	.	.
cord-011793-hlktpla4	58	1	n	n	NNP
cord-011793-hlktpla4	59	1	Effective	effective	JJ
cord-011793-hlktpla4	59	2	treatment	treatment	NN
cord-011793-hlktpla4	59	3	of	of	IN
cord-011793-hlktpla4	59	4	severe	severe	JJ
cord-011793-hlktpla4	59	5	COVID-19	covid-19	JJ
cord-011793-hlktpla4	59	6	patients	patient	NNS
cord-011793-hlktpla4	59	7	with	with	IN
cord-011793-hlktpla4	59	8	tocilizumab	tocilizumab	NNP
cord-011793-hlktpla4	59	9	Tissue	Tissue	NNP
cord-011793-hlktpla4	59	10	plasminogen	plasminogen	NN
cord-011793-hlktpla4	59	11	activator	activator	NN
cord-011793-hlktpla4	59	12	(	(	-LRB-
cord-011793-hlktpla4	59	13	tPA	tPA	NNP
cord-011793-hlktpla4	59	14	)	)	-RRB-
cord-011793-hlktpla4	59	15	treatment	treatment	NN
cord-011793-hlktpla4	59	16	for	for	IN
cord-011793-hlktpla4	59	17	COVID-19	covid-19	JJ
cord-011793-hlktpla4	59	18	associated	associated	JJ
cord-011793-hlktpla4	59	19	acute	acute	JJ
cord-011793-hlktpla4	59	20	respiratory	respiratory	JJ
cord-011793-hlktpla4	59	21	distress	distress	NN
cord-011793-hlktpla4	59	22	syndrome	syndrome	NN
cord-011793-hlktpla4	59	23	(	(	-LRB-
cord-011793-hlktpla4	59	24	ARDS	ARDS	NNP
cord-011793-hlktpla4	59	25	)	)	-RRB-
cord-011793-hlktpla4	59	26	:	:	:
cord-011793-hlktpla4	59	27	a	a	DT
cord-011793-hlktpla4	59	28	case	case	NN
cord-011793-hlktpla4	59	29	series	series	NN
cord-011793-hlktpla4	59	30	Evaluating	evaluate	VBG
cord-011793-hlktpla4	59	31	the	the	DT
cord-011793-hlktpla4	59	32	efficacy	efficacy	NN
cord-011793-hlktpla4	59	33	and	and	CC
cord-011793-hlktpla4	59	34	safety	safety	NN
cord-011793-hlktpla4	59	35	of	of	IN
cord-011793-hlktpla4	59	36	two	two	CD
cord-011793-hlktpla4	59	37	doses	dose	NNS
cord-011793-hlktpla4	59	38	of	of	IN
cord-011793-hlktpla4	59	39	the	the	DT
cord-011793-hlktpla4	59	40	polyclonal	polyclonal	JJ
cord-011793-hlktpla4	59	41	anti	anti	JJ
cord-011793-hlktpla4	59	42	-	-	JJ
cord-011793-hlktpla4	59	43	tumor	tumor	JJ
cord-011793-hlktpla4	59	44	necrosis	necrosis	NN
cord-011793-hlktpla4	59	45	factor	factor	NN
cord-011793-hlktpla4	59	46	-	-	:
cord-011793-hlktpla4	59	47	a	a	DT
cord-011793-hlktpla4	59	48	fragment	fragment	NN
cord-011793-hlktpla4	59	49	antibody	antibody	NN
cord-011793-hlktpla4	60	1	AZD9773	AZD9773	NNP
cord-011793-hlktpla4	60	2	in	in	IN
cord-011793-hlktpla4	60	3	adult	adult	NN
cord-011793-hlktpla4	60	4	patients	patient	NNS
cord-011793-hlktpla4	60	5	with	with	IN
cord-011793-hlktpla4	60	6	severe	severe	JJ
cord-011793-hlktpla4	60	7	sepsis	sepsis	NN
cord-011793-hlktpla4	61	1	and/or	and/or	CC
cord-011793-hlktpla4	61	2	septic	septic	JJ
cord-011793-hlktpla4	61	3	shock	shock	NN
cord-011793-hlktpla4	61	4	:	:	:
cord-011793-hlktpla4	62	1	randomized	randomized	JJ
cord-011793-hlktpla4	62	2	,	,	,
cord-011793-hlktpla4	62	3	double	double	JJ
cord-011793-hlktpla4	62	4	-	-	HYPH
cord-011793-hlktpla4	62	5	blind	blind	JJ
cord-011793-hlktpla4	62	6	,	,	,
cord-011793-hlktpla4	62	7	placebo	placebo	NN
cord-011793-hlktpla4	62	8	-	-	HYPH
cord-011793-hlktpla4	62	9	controlled	control	VBN
cord-011793-hlktpla4	62	10	phase	phase	NN
cord-011793-hlktpla4	62	11	IIb	iib	NN
cord-011793-hlktpla4	62	12	study	study	NN
cord-011793-hlktpla4	62	13	Effect	effect	NN
cord-011793-hlktpla4	62	14	of	of	IN
cord-011793-hlktpla4	62	15	intravenous	intravenous	JJ
cord-011793-hlktpla4	62	16	interferon	interferon	NN
cord-011793-hlktpla4	62	17	b-1a	b-1a	NN
cord-011793-hlktpla4	62	18	on	on	IN
cord-011793-hlktpla4	62	19	death	death	NN
cord-011793-hlktpla4	62	20	and	and	CC
cord-011793-hlktpla4	62	21	days	day	NNS
cord-011793-hlktpla4	62	22	free	free	JJ
cord-011793-hlktpla4	62	23	from	from	IN
cord-011793-hlktpla4	62	24	mechanical	mechanical	JJ
cord-011793-hlktpla4	62	25	ventilation	ventilation	NN
cord-011793-hlktpla4	62	26	among	among	IN
cord-011793-hlktpla4	62	27	patients	patient	NNS
cord-011793-hlktpla4	62	28	with	with	IN
cord-011793-hlktpla4	62	29	moderate	moderate	JJ
cord-011793-hlktpla4	62	30	to	to	IN
cord-011793-hlktpla4	62	31	severe	severe	JJ
cord-011793-hlktpla4	62	32	acute	acute	JJ
cord-011793-hlktpla4	62	33	respiratory	respiratory	JJ
cord-011793-hlktpla4	62	34	distress	distress	NN
cord-011793-hlktpla4	62	35	syndrome	syndrome	NN
cord-011793-hlktpla4	62	36	:	:	:
cord-011793-hlktpla4	62	37	a	a	DT
cord-011793-hlktpla4	62	38	randomized	randomized	JJ
cord-011793-hlktpla4	62	39	clinical	clinical	JJ
cord-011793-hlktpla4	62	40	trial	trial	NN
cord-011793-hlktpla4	62	41	Randomized	randomized	JJ
cord-011793-hlktpla4	62	42	clinical	clinical	JJ
cord-011793-hlktpla4	62	43	trial	trial	NN
cord-011793-hlktpla4	62	44	of	of	IN
cord-011793-hlktpla4	62	45	activated	activate	VBN
cord-011793-hlktpla4	62	46	protein	protein	NN
cord-011793-hlktpla4	62	47	C	C	NNP
cord-011793-hlktpla4	62	48	for	for	IN
cord-011793-hlktpla4	62	49	the	the	DT
cord-011793-hlktpla4	62	50	treatment	treatment	NN
cord-011793-hlktpla4	62	51	of	of	IN
cord-011793-hlktpla4	62	52	acute	acute	JJ
cord-011793-hlktpla4	62	53	lung	lung	NN
cord-011793-hlktpla4	62	54	injury	injury	NN
cord-011793-hlktpla4	62	55	National	National	NNP
cord-011793-hlktpla4	62	56	Heart	Heart	NNP
cord-011793-hlktpla4	62	57	,	,	,
cord-011793-hlktpla4	62	58	Lung	Lung	NNP
cord-011793-hlktpla4	62	59	,	,	,
cord-011793-hlktpla4	62	60	and	and	CC
cord-011793-hlktpla4	62	61	Blood	Blood	NNP
cord-011793-hlktpla4	62	62	Institute	Institute	NNP
cord-011793-hlktpla4	62	63	ARDS	ARDS	NNP
cord-011793-hlktpla4	62	64	Clinical	Clinical	NNP
cord-011793-hlktpla4	62	65	Trials	Trials	NNPS
cord-011793-hlktpla4	62	66	Network	Network	NNP
cord-011793-hlktpla4	62	67	.	.	.
cord-011793-hlktpla4	63	1	Rosuvastatin	Rosuvastatin	NNP
cord-011793-hlktpla4	63	2	for	for	IN
cord-011793-hlktpla4	63	3	sepsis	sepsis	NN
cord-011793-hlktpla4	63	4	-	-	HYPH
cord-011793-hlktpla4	63	5	associated	associate	VBN
cord-011793-hlktpla4	63	6	acute	acute	JJ
cord-011793-hlktpla4	63	7	respiratory	respiratory	JJ
cord-011793-hlktpla4	63	8	distress	distress	NN
cord-011793-hlktpla4	63	9	syndrome	syndrome	NN
cord-011793-hlktpla4	63	10	Infectious	Infectious	NNP
cord-011793-hlktpla4	63	11	Disease	Disease	NNP
cord-011793-hlktpla4	63	12	Society	Society	NNP
cord-011793-hlktpla4	63	13	of	of	IN
cord-011793-hlktpla4	63	14	America	America	NNP
cord-011793-hlktpla4	63	15	guidelines	guideline	NNS
cord-011793-hlktpla4	63	16	on	on	IN
cord-011793-hlktpla4	63	17	the	the	DT
cord-011793-hlktpla4	63	18	treatment	treatment	NN
cord-011793-hlktpla4	63	19	and	and	CC
cord-011793-hlktpla4	63	20	management	management	NN
cord-011793-hlktpla4	63	21	of	of	IN
cord-011793-hlktpla4	63	22	patients	patient	NNS
cord-011793-hlktpla4	63	23	with	with	IN
cord-011793-hlktpla4	63	24	COVID-19	covid-19	JJ
cord-011793-hlktpla4	63	25	infection	infection	NN
cord-011793-hlktpla4	63	26	Outcomes	outcome	NNS
cord-011793-hlktpla4	63	27	and	and	CC
cord-011793-hlktpla4	63	28	statistical	statistical	JJ
cord-011793-hlktpla4	63	29	power	power	NN
cord-011793-hlktpla4	63	30	in	in	IN
cord-011793-hlktpla4	63	31	adult	adult	NN
cord-011793-hlktpla4	63	32	critical	critical	JJ
cord-011793-hlktpla4	63	33	care	care	NN
cord-011793-hlktpla4	63	34	randomized	randomized	JJ
cord-011793-hlktpla4	63	35	trials	trial	NNS
cord-011793-hlktpla4	64	1	COVID-19	COVID-19	NNP
cord-011793-hlktpla4	64	2	does	do	VBZ
cord-011793-hlktpla4	64	3	not	not	RB
cord-011793-hlktpla4	64	4	lead	lead	VB
cord-011793-hlktpla4	64	5	to	to	IN
cord-011793-hlktpla4	64	6	a	a	DT
cord-011793-hlktpla4	64	7	"	"	``
cord-011793-hlktpla4	64	8	typical	typical	JJ
cord-011793-hlktpla4	64	9	"	"	''
cord-011793-hlktpla4	64	10	acute	acute	JJ
cord-011793-hlktpla4	64	11	respiratory	respiratory	JJ
cord-011793-hlktpla4	64	12	distress	distress	NN
cord-011793-hlktpla4	64	13	syndrome	syndrome	NN
cord-011793-hlktpla4	64	14	Acute	Acute	NNP
cord-011793-hlktpla4	64	15	Respiratory	Respiratory	NNP
cord-011793-hlktpla4	64	16	Distress	Distress	NNP
cord-011793-hlktpla4	64	17	Syndrome	Syndrome	NNP
cord-011793-hlktpla4	64	18	Network	Network	NNP
cord-011793-hlktpla4	64	19	.	.	.
cord-011793-hlktpla4	65	1	Ventilation	ventilation	NN
cord-011793-hlktpla4	65	2	with	with	IN
cord-011793-hlktpla4	65	3	lower	low	JJR
cord-011793-hlktpla4	65	4	tidal	tidal	JJ
cord-011793-hlktpla4	65	5	volumes	volume	NNS
cord-011793-hlktpla4	65	6	as	as	IN
cord-011793-hlktpla4	65	7	compared	compare	VBN
cord-011793-hlktpla4	65	8	with	with	IN
cord-011793-hlktpla4	65	9	traditional	traditional	JJ
cord-011793-hlktpla4	65	10	tidal	tidal	JJ
cord-011793-hlktpla4	65	11	volumes	volume	NNS
cord-011793-hlktpla4	65	12	for	for	IN
cord-011793-hlktpla4	65	13	acute	acute	JJ
cord-011793-hlktpla4	65	14	lung	lung	NN
cord-011793-hlktpla4	65	15	injury	injury	NN
cord-011793-hlktpla4	65	16	and	and	CC
cord-011793-hlktpla4	65	17	the	the	DT
cord-011793-hlktpla4	65	18	acute	acute	JJ
cord-011793-hlktpla4	65	19	respiratory	respiratory	JJ
cord-011793-hlktpla4	65	20	distress	distress	NN
cord-011793-hlktpla4	65	21	syndrome	syndrome	NN
cord-011793-hlktpla4	65	22	Tidal	tidal	JJ
cord-011793-hlktpla4	65	23	volume	volume	NN
cord-011793-hlktpla4	65	24	reduction	reduction	NN
cord-011793-hlktpla4	65	25	in	in	IN
cord-011793-hlktpla4	65	26	patients	patient	NNS
cord-011793-hlktpla4	65	27	with	with	IN
cord-011793-hlktpla4	65	28	acute	acute	JJ
cord-011793-hlktpla4	65	29	lung	lung	NN
cord-011793-hlktpla4	65	30	injury	injury	NN
cord-011793-hlktpla4	65	31	when	when	WRB
cord-011793-hlktpla4	65	32	plateau	plateau	NN
cord-011793-hlktpla4	65	33	pressures	pressure	NNS
cord-011793-hlktpla4	65	34	are	be	VBP
cord-011793-hlktpla4	65	35	not	not	RB
cord-011793-hlktpla4	65	36	high	high	JJ
cord-011793-hlktpla4	65	37	IMPROVE	IMPROVE	NNP
cord-011793-hlktpla4	65	38	Study	Study	NNP
cord-011793-hlktpla4	65	39	Group	Group	NNP
cord-011793-hlktpla4	65	40	.	.	.
cord-011793-hlktpla4	66	1	A	a	DT
cord-011793-hlktpla4	66	2	trial	trial	NN
cord-011793-hlktpla4	66	3	of	of	IN
cord-011793-hlktpla4	66	4	intraoperative	intraoperative	JJ
cord-011793-hlktpla4	66	5	low	low	RB
cord-011793-hlktpla4	66	6	-	-	HYPH
cord-011793-hlktpla4	66	7	tidal	tidal	JJ
cord-011793-hlktpla4	66	8	-	-	HYPH
cord-011793-hlktpla4	66	9	volume	volume	NN
cord-011793-hlktpla4	66	10	ventilation	ventilation	NN
cord-011793-hlktpla4	66	11	in	in	IN
cord-011793-hlktpla4	66	12	abdominal	abdominal	JJ
cord-011793-hlktpla4	66	13	surgery	surgery	NN
cord-011793-hlktpla4	66	14	Higher	higher	RBR
cord-011793-hlktpla4	66	15	vs	vs	IN
cord-011793-hlktpla4	66	16	lower	low	JJR
cord-011793-hlktpla4	66	17	positive	positive	JJ
cord-011793-hlktpla4	66	18	end	end	NN
cord-011793-hlktpla4	66	19	-	-	HYPH
cord-011793-hlktpla4	66	20	expiratory	expiratory	NN
cord-011793-hlktpla4	66	21	pressure	pressure	NN
cord-011793-hlktpla4	66	22	in	in	IN
cord-011793-hlktpla4	66	23	patients	patient	NNS
cord-011793-hlktpla4	66	24	with	with	IN
cord-011793-hlktpla4	66	25	acute	acute	JJ
cord-011793-hlktpla4	66	26	lung	lung	NN
cord-011793-hlktpla4	66	27	injury	injury	NN
cord-011793-hlktpla4	66	28	and	and	CC
cord-011793-hlktpla4	66	29	acute	acute	JJ
cord-011793-hlktpla4	66	30	respiratory	respiratory	JJ
cord-011793-hlktpla4	66	31	distress	distress	NN
cord-011793-hlktpla4	66	32	syndrome	syndrome	NN
cord-011793-hlktpla4	66	33	:	:	:
cord-011793-hlktpla4	66	34	systematic	systematic	JJ
cord-011793-hlktpla4	66	35	review	review	NN
cord-011793-hlktpla4	66	36	and	and	CC
cord-011793-hlktpla4	66	37	meta	meta	NNP
cord-011793-hlktpla4	66	38	-	-	HYPH
cord-011793-hlktpla4	66	39	analysis	analysis	NN
cord-011793-hlktpla4	66	40	PROSEVA	PROSEVA	NNP
cord-011793-hlktpla4	66	41	Study	Study	NNP
cord-011793-hlktpla4	66	42	Group	Group	NNP
cord-011793-hlktpla4	66	43	.	.	.
cord-011793-hlktpla4	67	1	Prone	prone	JJ
cord-011793-hlktpla4	67	2	positioning	positioning	NN
cord-011793-hlktpla4	67	3	in	in	IN
cord-011793-hlktpla4	67	4	severe	severe	JJ
cord-011793-hlktpla4	67	5	acute	acute	JJ
cord-011793-hlktpla4	67	6	respiratory	respiratory	JJ
cord-011793-hlktpla4	67	7	distress	distress	NN
cord-011793-hlktpla4	67	8	syndrome	syndrome	NN
cord-011793-hlktpla4	67	9	National	National	NNP
cord-011793-hlktpla4	67	10	Heart	Heart	NNP
cord-011793-hlktpla4	67	11	,	,	,
cord-011793-hlktpla4	67	12	Lung	Lung	NNP
cord-011793-hlktpla4	67	13	,	,	,
cord-011793-hlktpla4	67	14	and	and	CC
cord-011793-hlktpla4	67	15	Blood	Blood	NNP
cord-011793-hlktpla4	67	16	Institute	Institute	NNP
cord-011793-hlktpla4	67	17	Acute	Acute	NNP
cord-011793-hlktpla4	67	18	Respiratory	Respiratory	NNP
cord-011793-hlktpla4	67	19	Distress	Distress	NNP
cord-011793-hlktpla4	67	20	Syndrome	Syndrome	NNP
cord-011793-hlktpla4	67	21	(	(	-LRB-
cord-011793-hlktpla4	67	22	ARDS	ARDS	NNP
cord-011793-hlktpla4	67	23	)	)	-RRB-
cord-011793-hlktpla4	67	24	Clinical	Clinical	NNP
cord-011793-hlktpla4	67	25	Trials	Trials	NNPS
cord-011793-hlktpla4	67	26	Network	Network	NNP
cord-011793-hlktpla4	67	27	.	.	.
cord-011793-hlktpla4	68	1	Comparison	comparison	NN
cord-011793-hlktpla4	68	2	of	of	IN
cord-011793-hlktpla4	68	3	two	two	CD
cord-011793-hlktpla4	68	4	fluid	fluid	JJ
cord-011793-hlktpla4	68	5	-	-	HYPH
cord-011793-hlktpla4	68	6	management	management	NN
cord-011793-hlktpla4	68	7	strategies	strategy	NNS
cord-011793-hlktpla4	68	8	in	in	IN
cord-011793-hlktpla4	68	9	acute	acute	JJ
cord-011793-hlktpla4	68	10	lung	lung	NN
cord-011793-hlktpla4	68	11	injury	injury	NN
cord-011793-hlktpla4	68	12	Efficacy	Efficacy	NNP
cord-011793-hlktpla4	68	13	and	and	CC
cord-011793-hlktpla4	68	14	safety	safety	NN
cord-011793-hlktpla4	68	15	of	of	IN
cord-011793-hlktpla4	68	16	a	a	DT
cord-011793-hlktpla4	68	17	paired	paired	JJ
cord-011793-hlktpla4	68	18	sedation	sedation	NN
cord-011793-hlktpla4	68	19	and	and	CC
cord-011793-hlktpla4	68	20	ventilator	ventilator	NN
cord-011793-hlktpla4	68	21	weaning	wean	VBG
cord-011793-hlktpla4	68	22	protocol	protocol	NN
cord-011793-hlktpla4	68	23	for	for	IN
cord-011793-hlktpla4	68	24	mechanically	mechanically	RB
cord-011793-hlktpla4	68	25	ventilated	ventilate	VBN
cord-011793-hlktpla4	68	26	patients	patient	NNS
cord-011793-hlktpla4	68	27	in	in	IN
cord-011793-hlktpla4	68	28	intensive	intensive	JJ
cord-011793-hlktpla4	68	29	care	care	NN
cord-011793-hlktpla4	68	30	(	(	-LRB-
cord-011793-hlktpla4	68	31	Awakening	Awakening	NNP
cord-011793-hlktpla4	68	32	and	and	CC
cord-011793-hlktpla4	68	33	Breathing	Breathing	NNP
cord-011793-hlktpla4	68	34	Controlled	Controlled	NNP
cord-011793-hlktpla4	68	35	trial	trial	NN
cord-011793-hlktpla4	68	36	)	)	-RRB-
cord-011793-hlktpla4	68	37	:	:	:
cord-011793-hlktpla4	68	38	a	a	DT
cord-011793-hlktpla4	68	39	randomised	randomised	JJ
cord-011793-hlktpla4	68	40	controlled	control	VBN
cord-011793-hlktpla4	68	41	trial	trial	NN
cord-011793-hlktpla4	68	42	An	an	DT
cord-011793-hlktpla4	68	43	intervention	intervention	NN
cord-011793-hlktpla4	68	44	to	to	TO
cord-011793-hlktpla4	68	45	decrease	decrease	VB
cord-011793-hlktpla4	68	46	catheter	catheter	NN
cord-011793-hlktpla4	68	47	-	-	HYPH
cord-011793-hlktpla4	68	48	related	relate	VBN
cord-011793-hlktpla4	68	49	bloodstream	bloodstream	NN
cord-011793-hlktpla4	68	50	infections	infection	NNS
cord-011793-hlktpla4	68	51	in	in	IN
cord-011793-hlktpla4	68	52	the	the	DT
cord-011793-hlktpla4	68	53	ICU	ICU	NNP
cord-011793-hlktpla4	68	54	Pragmatic	pragmatic	JJ
cord-011793-hlktpla4	68	55	recommendations	recommendation	NNS
cord-011793-hlktpla4	68	56	for	for	IN
cord-011793-hlktpla4	68	57	intubating	intubate	VBG
cord-011793-hlktpla4	68	58	critically	critically	RB
cord-011793-hlktpla4	68	59	ill	ill	JJ
cord-011793-hlktpla4	68	60	patients	patient	NNS
cord-011793-hlktpla4	68	61	with	with	IN
cord-011793-hlktpla4	68	62	suspected	suspect	VBN
cord-011793-hlktpla4	68	63	COVID-19	COVID-19	NNP
cord-011793-hlktpla4	68	64	Surviving	Surviving	NNP
cord-011793-hlktpla4	68	65	sepsis	sepsis	NN
cord-011793-hlktpla4	68	66	campaign	campaign	NN
cord-011793-hlktpla4	68	67	:	:	:
cord-011793-hlktpla4	68	68	guidelines	guideline	NNS
cord-011793-hlktpla4	68	69	on	on	IN
cord-011793-hlktpla4	68	70	the	the	DT
cord-011793-hlktpla4	68	71	management	management	NN
cord-011793-hlktpla4	68	72	of	of	IN
cord-011793-hlktpla4	68	73	critically	critically	RB
cord-011793-hlktpla4	68	74	ill	ill	JJ
cord-011793-hlktpla4	68	75	adults	adult	NNS
cord-011793-hlktpla4	68	76	with	with	IN
cord-011793-hlktpla4	68	77	coronavirus	coronavirus	NN
cord-011793-hlktpla4	68	78	disease	disease	NN
cord-011793-hlktpla4	68	79	2019	2019	CD
cord-011793-hlktpla4	68	80	(	(	-LRB-
cord-011793-hlktpla4	68	81	COVID-19	COVID-19	NNP
cord-011793-hlktpla4	68	82	)	)	-RRB-
cord-011793-hlktpla4	68	83	Australian	australian	JJ
cord-011793-hlktpla4	68	84	and	and	CC
cord-011793-hlktpla4	68	85	New	New	NNP
cord-011793-hlktpla4	68	86	Zealand	Zealand	NNP
cord-011793-hlktpla4	68	87	Intensive	Intensive	NNP
cord-011793-hlktpla4	68	88	Care	Care	NNP
cord-011793-hlktpla4	68	89	Society	Society	NNP
cord-011793-hlktpla4	68	90	.	.	.
cord-011793-hlktpla4	69	1	ANZICS	ANZICS	NNP
cord-011793-hlktpla4	70	1	COVID-19	COVID-19	NNP
cord-011793-hlktpla4	70	2	Guidelines	Guidelines	NNPS
cord-011793-hlktpla4	70	3	.	.	.
cord-011793-hlktpla4	71	1	Melbourne	Melbourne	NNP
cord-011793-hlktpla4	71	2	:	:	:
cord-011793-hlktpla4	71	3	ANZICS	anzic	NNS
cord-011793-hlktpla4	71	4	;	;	:
cord-011793-hlktpla4	71	5	2020	2020	CD
cord-011793-hlktpla4	71	6	High	high	JJ
cord-011793-hlktpla4	71	7	-	-	HYPH
cord-011793-hlktpla4	71	8	flow	flow	NN
cord-011793-hlktpla4	71	9	oxygen	oxygen	NN
cord-011793-hlktpla4	71	10	through	through	IN
cord-011793-hlktpla4	71	11	nasal	nasal	NN
cord-011793-hlktpla4	71	12	cannula	cannula	NN
cord-011793-hlktpla4	71	13	in	in	IN
cord-011793-hlktpla4	71	14	acute	acute	JJ
cord-011793-hlktpla4	71	15	hypoxemic	hypoxemic	NN
cord-011793-hlktpla4	72	1	respiratory	respiratory	JJ
cord-011793-hlktpla4	72	2	failure	failure	NN
cord-011793-hlktpla4	73	1	Author	author	NN
cord-011793-hlktpla4	73	2	disclosures	disclosure	NNS
cord-011793-hlktpla4	73	3	are	be	VBP
cord-011793-hlktpla4	73	4	available	available	JJ
cord-011793-hlktpla4	73	5	with	with	IN
cord-011793-hlktpla4	73	6	the	the	DT
cord-011793-hlktpla4	73	7	text	text	NN
cord-011793-hlktpla4	73	8	of	of	IN
cord-011793-hlktpla4	73	9	this	this	DT
cord-011793-hlktpla4	73	10	article	article	NN
cord-011793-hlktpla4	73	11	at	at	IN
cord-011793-hlktpla4	73	12	www.atsjournals.org	www.atsjournals.org	NN
cord-011793-hlktpla4	73	13	.	.	.